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characterized through sedimentation and circular dichroism measurements.  
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1I. Introduction
The goal of this thesis work was to obtain active recombinant viral capsid protein 
of Turnip crinkle virus (TCV) for further experimentation on virus assembly and its 
relationship to suppression of virus-induced gene silencing (VIGS) in plants. Specifically, 
the TCV coat protein gene has been cloned and the recombinant protein expressed and 
purified from Escherichia coli. The purified protein has been characterized for future use 
in determining the mechanism of its assembly into virions and the relationship between 
virion assembly and the role of the coat protein in inhibiting gene silencing. The topics 
covered in this introduction are intended to clarify, in general and with respect to TCV, 
the icosahedral structure, proposed mechanism of assembly and the role of the viral coat 
protein in VIGS.          
A. Virus Classification
A virus is an obligate infectious parasite that uses a host organism during part of 
its life cycle. Its survival depends on its ability to utilize the infected host’s machinery 
and stored energy in order to replicate its own genome. The infectious form of the virus is 
the complete virus particle or virion. The interior genome and exterior shell, or capsid, 
together form the nucleoprotein particle. Some viruses also contain a lipid membrane and 
associated proteins or viral envelope that surrounds the capsid (1). The virus must be able 
to package its genetic material into a stable virion that can withstand the harsh exterior 
2environment and disassemble readily once inside a newly infected host cell. Once inside 
the host it must be able to transport its genetic material from one infected cell to another. 
Viruses can be classified based on the symmetry of the protein arrangement that 
forms the capsid. Three broad classes can be defined including helical, icosahedral and 
complex virions. In the helical arrangement proteins arrange themselves around a single 
central axis while an icosahedral arrangement is classified by the virion’s spherical outer 
shell with 2, 3 and 5-fold axes of symmetry. These classes can be broken down further 
based on the type of nucleic acid, either single-stranded, double-stranded, DNA or RNA,
the presence of an outer lipid envelope and various other structural features (1). 
B. Icosahedral Virus Structure
1. Virion Structure
The structure of the virion is defined by the coat protein arrangement around the 
interior genome. In the case of the icosahedral virus the proteins arrange to resemble a 
sphere. Not all viruses are spherical in shape and some, such as the helical Tobacco 
mosaic virus, form rods of different lengths depending on the length of the genome (see 
Figure 1 a & b). Unlike helical viruses that do not have a set maximum length on the 
genetic material that can be packaged, icosahedral viruses have a predetermined genome 
size length due to the limited internal volume of the capsid. 
3The simplest example of an icosahedral virion is comprised of 20 triangular faces 
each consisting of three CP subunits. Thus, the smallest number of subunits that can be 
packaged to form an icosahedron is 60 (triangulation number or T = 1). As the virion size 
increases it does so by a factor of 60 subunits so that T > 1. In a T = 1 virion, all subunits 
in each face have identical conformations and subunit- subunit interactions. These virions 
contain 2-fold, 3-fold and 5-fold axes of symmetry (see Figure 1 c & d). Due to the 
limited amount of internal packaging space for the genome there are only a few known T 
= 1 virions. Most icosahedral viruses are larger in size and consist of more CPs with an 
accompanying increased triangulation number (1). The T >1, unlike the T = 1 capsids, 
consist of hexamer, planar orientation, and pentamer, produced by removing one subunit 
from a planar hexamer assembly so a convex pentamer can form at each vertex, 
assemblies of the CPs. Pentamers are inserted into a hexagonal sequence so a closed shell 
can form with the proper symmetry (2). Since the same structural component is used in 
both subassemblies the interactions are not equivalent. Unlike the T = 1 capsids the 
subunits of larger viruses are not identical and instead exhibit differences in subunit 
interactions and conformations, a property known as quasiequivalence (3). The TCV 
capsid is comprised of 180 CP subunits and has T = 3 symmetry.
4Figure 1. Helical and icosahedral symmetry. (a) Helical TMV virions negatively stained. 
The bar represents 100 nm . From http://www.dpvweb.net (b) Icosahedral TCV virions 
stained with potassium phosphotungstate. The bar represents 100 nm. From 
http://www.dpvweb.net (c) The structures of T = 1 and T = 3 icosahedral virions with the 
three different coat protein subunits (A, B, C) per face in the T = 3 virion indicated by 
varying color. Green represents the A subunit, red the B subunit and blue the C subunit. 
From http://www.tulane.edu/~dmsander/WWW/224/Structure224.html (d) Icosahedral 
symmetry, with axes of 2, 3, and 5-fold symmetry indicated (1).
(a) (b)
T = 1 T = 3 T = 3
(c)
(d)
52. Coat protein structure  
In 1986 the x-ray crystallographic structure of TCV was resolved to 3.2Å 
resolution and was found to be very similar to that of Tomato bushy stunt virus (TBSV) 
another T = 3 icosahedral virus (4). The similarity in structure of these two viruses was 
first reported in earlier work using low resolution x-ray diffraction and electron 
microscopy (5). Once the structure was resolved at high resolution it was observed to 
contain similar elements to TBSV both with respect to the complete virion and the 
individual coat protein subunits (4).  Each face of the icosahedral virion contains three 
CP subunits that interact with each other and the internally packaged genomic RNA. The 
structure of these subunits is similar between viruses with specific repeating structural 
elements or motifs. In the case of TCV the CP contains three main domains, the N-
terminal random (R) domain, the shell (S) domain and the protruding (P) domain (see 
Figure 2). The R domain has a basic N-terminus that can extend into the interior of the 
virus particle where it can interact with the positive-sense RNA. It is not normally visible 
in x-ray crystallography due to its conformational flexibility.  This domain is linked by an 
“arm” region to the S domain, which consists of an eight-stranded antiparallel -sheet or 
-barrel jellyroll, with the inserts between these strands pointed outward, forming the 
virion shell (4). There are a limited number of different tertiary structural motifs found in 
the CPs of different viruses but the -barrel is the most common. It is not only found in 
plant but also vertebrate, insect and bacterial viruses (2). The P domain, which protrudes 
out from the virion’s surface is connected to the S domain via a hinge (4). The only 
domain that is conserved in all plant RNA viral CPs is the shell (S) domain. The presence 
6of the protruding (P) domain is a feature of the Carmovirus genus in the Tombusviridae
family (6). 
 
Figure 2. TCV virion and coat protein structure. (a) Linear representation of the order of 
the domains in the CP from the N-terminus to the C-terminus. (b) Representation of a T = 
3 virion with the three different CP subunits indicated by color. The oval represents the 
two-fold axis, the triangle the three-fold axis and the pentagon the five- fold axis (7). (c) 
TCV virion indicating the A, B and C packaging environments of the CP (8). (d) A 
space-filling representation of the carbon-nitrogen backbone of the TCV CP subunit (9). 
 
As indicated above, viruses like TCV with larger triangulation numbers exhibit 
quasiequivalence in their coat protein subunit interactions. These domains can exist in 
different conformations depending on the packaging environment. There are three 
distinct CP packaging conformations present: A, B and C, which together form each face 
N CR  a S P
52   29        162       5      103
(a)
(b) (c)
 h
S domain
R 
domain
P domain
(d)
7on the capsid surface (see Figure 2b). Conformations A and B have similar S and P 
domain orientations with the R domain arms in a disordered state. The C conformation 
has a different hinge angle, resulting in slightly different relative S and P domain 
orientations, with the R domain arm ordered. From the 180 subunits that comprise the 
virion structure 120 of these are A and B subunits while the remaining 60 subunits are in 
the C conformation. Each ordered arm from one C subunit interacts with arms from two 
other C subunits to form a -annulus structure that interacts with the genomic RNA at the 
3-fold axis. In this manner the C subunits are thought to dictate the size and the T = 3 
structure of the virion. Each subunit dimer’s P domains form the protruding structures for 
which they are named, producing a total of 90 protruding structures for each virion (8). 
3. RNA and replication
Icosahedral viruses can contain RNA or DNA, either single-stranded or double-
stranded, although most icosahedral viruses contain single-stranded RNA. Even with this 
variation in the type/ form of the genetic material, they all contain genomes of a 
predetermined size. With single-stranded RNA viruses once the virion enters the host cell 
it dissociates allowing the immediate translation of the viral-RNA dependent RNA 
polymerase (RdRp) directly from the positive-sense RNA genome. This enzyme can then 
transcribe the negative-sense RNA template needed to produce more positive-sense RNA 
for packaging and the other subgenomic RNAs. Those RNA genomes that encode more 
than one gene have the first gene or open reading frame directly translated from the 
genome while the other downstream genes are expressed off of subgenomic RNAs (10).  
8In many cases the genome and subgenomic RNAs are divided into a series of open 
reading frames that each encode a particular required protein. Translation can then occur 
producing the appropriate proteins needed for assembly, movement through the host and 
other required functions. 
TCV, like many icosahedral viruses, contains one copy of a positive-sense 4054 
base single-stranded RNA genome that is encapsulated by 180 copies of the 38 kDa coat 
protein (TCV CP) in the virion structure (11). The RNA consists of five open reading 
frames (ORFs), encoding the five viral proteins, expressed from the genomic and two 
subgenomic RNAs, sgRNA1 and sgRNA2 (see Figure 3) (12).  Both p28 and p88 are 
directly translated from the genomic RNA. Translation of p88 is by read-through of the 
p28 amber termination codon, and the two protein products comprise the viral RNA-
dependent RNA-polymerase (RdRp) needed for replication of the genome and two 
subgenomic RNAs (13). The movement proteins p8 and p9 are translated from 
overlapping ORFs of the 1721 base sgRNA1 (14). Both are implicated in cell-to-cell and 
systematic spread of the virus in vivo (13). The 1447 base sgRNA2 codes for the p38 or 
CP which has been implicated in: (1) virion assembly (2) movement (13) (3) repression 
of satC replication (15) (4) suppression of gene silencing (16, 17) and (5) symptom 
modulation in the presence of satC (18). 
 
9Figure 3. A representation of the coding regions on the TCV genomic RNA that encode 
for the various viral proteins associated with TCV. The genomic and two subgenomic 
RNAs are also depicted above.
C. Models of Virion Assembly
A coat protein’s main function is assembly of the virion into its appropriate 
symmetrical structure. The genomic RNA must be packaged and surrounded by an 
exterior shell to protect the genome from potential degradation outside the host organism. 
For viruses that do not have an outer lipid envelope encapsidation results in the formation 
of the complete virion. Since the coat proteins form the capsid they must be able to first 
recognize the correct nucleic acid sequence or viral genome and package it during the 
appropriate time frame of the infection process. If packaging occurs too early the genome 
will be sequestered before it has a chance to act as the template for replication. In order to 
ensure proper timing of encapsidation the coat protein is translated from a subgenomic 
RNA, as described previously (2, 10). This allows for a pool of new genetic information 
to be established and ready for encapsidation once the coat protein is produced. Not only 
must the coat protein be translated after genome replication, once ready for packaging it 
must also be able to recognize the genomic RNA, bind and initiate assembly. As a 
p28 p88 p8 p9 p38 (CP)
genomic RNA 
sgRNA1 (1.72 kb)
sgRNA2 (1.45 kb)
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method of identification the protein or protein complex must be able to recognize a 
particular sequence, termed the nucleation site, on the genome to which it can bind and 
initiate packaging. Once bound, the protein(s) recruit other coat proteins that then form 
protein-protein interactions with each other and protein-nucleic acid interactions with the 
genome (1, 2). These latter protein-nucleic acid interactions may be less sequence 
specific than those formed with the nucleation site for protein binding and instead are a 
result of the outer folded geometry of the genome. There are different models for how 
virions assemble and at what point during the process the genome attains its folded 
conformation. 
1. Tobacco Mosaic Virus (TMV)
The best-known assembly model and characterized nucleation site is for the 
helical Tobacco mosaic virus. This virion is a right-handed single helix with a 6395 
nucleotide RNA genome intercalated between successive turns of a 300nm long 18nm 
wide helix with an interior space of 2nm. It consists of 131 turns with 16 1/3 subunits per 
helical turn for a total incorporation of 2130 coat protein subunits (see Figure 4) (19). 
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Figure 4. A schematic representation of the different structures produced by TMV during 
assembly. (a) Depicts the two ring aggregate, (b) the procapsid and (c) the complete 
TMV particle (19). 
The nucleation site for assembly of TMV has been identified and characterized 
through assembly and site-directed mutagenesis studies. The origin of assembly was 
originally identified through nuclease protection studies (20, 21) and is located at about 
1000 nucleotides from the 3' end of the genome from nucleotide 5420 to 5546 (see Figure 
5) (22, 23). This core region forms a stem-loop structure and it was observed that in vivo, 
while coexpressing the TMV coat protein, this region alone was sufficient to allow 
encapsidation of foreign RNAs (24, 25). A series of studies were then carried out in 
which particular sites in the stem-loop sequence were mutated and the rate of assembly 
was measured in vitro. When the AAGAAGUCG sequence that forms the loop in the 
stem-loop structure was replaced by either a (CCG)3 or an (A)9 sequence the rate of 
(a) (b) (c)
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assembly decreased by 750 and 3000 fold, respectively. By contrast, a replacement 
sequence of either (UUG)3 or (GUG)3 where the G was kept in every third position did 
not have a significant effect on the assembly rate. If the G was either removed or C 
residues were inserted into the sequence the rate of assembly decreased. It was 
determined that the triplet G repeat was required in the stem-loop while C residues were 
unfavorable. To determine if the position of the loop in the genome was an important 
factor in initiating assembly the stem sequence and stem length were varied. It was found 
that the overall sequence was unimportant but that the stem length was the determining 
factor. If either the stem was shortened or the bottom loop was removed the rate of 
assembly decreased (26). The main features required for a nucleation site comparable to 
wild-type TMV that allowed assembly included a single-stranded loop sequence with a G 
repeat at every third base, a weakly base paired stem and the correct distance of the lower 
stem and loop region (19). 
 
Figure 5. This is the origin of assembly on the TMV RNA ( 19). 
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In 1984 Butler proposed the model for the nucleation of TMV assembly. It had 
been observed in earlier studies that a large aggregate or “disk” of the coat protein could 
form which consisted of two rings of 17 subunits each. The rate of assembly increased 
with the addition of these disk aggregates compared to assembly studies with a mixture of 
smaller aggregates termed A-proteins (19). The helix was also formed in the absence of 
RNA at a low pH and by comparing the protein helix to the nucleoprotein helix the 
structure of the interior genomic RNA was resolved (27, 28). From the RNA structure it 
was determined that each CP bound to a three-nucleotide region on the genomic RNA 
(28). Butler’s proposed model of assembly consisted of a nucleation reaction step and an 
elongation reaction step (see Figure 6). During the nucleation reaction the nucleation site 
first inserted itself into the disk and bound causing the weakly base paired stem to melt 
and generate more single-stranded RNA, which was then available to bind to neighboring 
subunits until a complete turn was bound. The energy from this interaction allowed the 
assembly to transition from a disk to a proto-helix structure. This rearranged the protein 
subunits so the RNA could become trapped between the two layers of the rings allowing 
the RNA to bind to both the top and bottom surfaces of each protein layer. At this point 
elongation or the addition of more coat protein subunits proceeded in both directions. The 
elongation occurred at a faster rate toward the 5' end since disk aggregates were added 
onto the traveling loop of RNA. The 3' end elongation proceeds at a slower rate since 
smaller aggregates or A-proteins were added on (29). 
14
Figure 6.  A picture of the proposed TMV assembly process which includes (a) the 
mechanism of nucleation and (b) the mechanism of elongation (19, 29). 
(a)
(b)
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2. Icosahedral Virus Assembly
Unlike the well-documented helical virus model of assembly the mechanism of 
assembly of icosahedral viruses is still not well understood. The proposed model for 
TMV assembly with its characterized nucleation site has influenced subsequent assembly 
studies performed with icosahedral viruses. The concept of a nucleation site that must 
bind CP in order to initiate selective packaging of the viral RNA was adopted as a 
universal nucleation step for virus assembly. It has consequently been incorporated into 
various proposed models for assembly of icosahedral viruses. There are two main current 
assembly models, either the coat protein binds to the nucleation site on the RNA 
initiating assembly or a procapsid structure is formed which then binds to the genome and 
draws it into the interior through a gap in the capsid. The second model is observed 
specifically with DNA viruses such as some bacteriophages while the first model is the 
more accepted for RNA icosahedral assembly although even this model consists of two 
possible pathways based on the folding of the RNA (1). Either, as proposed for Cowpea 
chlorotic mottle virus, the coat protein or a complex of coat proteins can bind to the RNA 
and initiate a RNA conformational change or as suggested for Bean pod mottle virus and 
nodavirus, the RNA folds prior to the initial CP binding and the geometry of the RNA 
influences the coat protein assembly (7, 30). 
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a. Cowpea Chlorotic Mottle Virus (CCMV)
One example of a single-stranded positive sense icosahedral virus that has been 
subjected to assembly studies is the Bromovirus CCMV. It contains a tripartite genome 
and three morphologically identical virions each contain essential genetic information 
needed for the infection process. The RNA 1 and RNA 2, which each code for proteins 
needed during replication are packaged in separate virions while RNA 3, the mRNA for 
the 32 kDa movement protein and RNA 4, a subgenomic mRNA for the 20 kDa coat 
protein expressed from RNA3, are packaged in a 1:1 ratio in another virion. Since the 
coat protein can form empty capsids under low pH and moderate ionic strength 
conditions it has been a useful model for assembly (30). In 1995 Johnson determined the 
virion structure to 3.3 Å resolution by x-ray crystallography (31). This crystal structure 
revealed the presence of a tubular -barrel structure, termed the -hexamer, where the N-
termini, amino acids 29 to 33, of the three-fold coat protein subunits converged at the 
quasi-six fold vertices (see Figure 7). From the virion structure it was proposed that the 
basic assembly unit would consist of a noncovalent dimer. The presence of the -
hexamer and the noncovalent dimer suggested that assembly might be initiated by a 
hexamer of dimers where the free N-terminus from the three-fold coat protein subunit of 
each dimer interacts to form the -hexamer which can then act as a stability factor (31). 
In 2000 Zlotnick, using light scattering and size-exclusion chromatography techniques 
combined with assembly experiments determined that the hexamer was most likely not 
the species of initiation. They observed that not only could the coat protein form 
pentamers of dimers readily in solution but that capsid assembly was nucleated by a 
pentamer of coat protein dimers. It was then speculated that assembly could progress by 
17
cooperative addition of coat protein subunit dimers (32). Once the -hexamer was 
determined not to initiate assembly its influence on the assembly process was then 
investigated. A series of mutational studies in conjunction with assembly assays both in
vitro and in vivo concluded that the structure was not necessary for virion formation but 
does contribute to overall virion stability (33).   
Figure 7. Structural features of CCMV. (A) Diagram of the CCMV CP. The -strand 
involved in the -hexamer formation is labeled. (B) Depicts the hexamer viewed down 
the three-fold axis. (C) Representation of the -hexamer motif (33). 
 
A
B
C
18
A new model was proposed in 2004 based on in vitro measurements of assembly 
of the CCMV RNA-containing virus-like particles (VLPs; see Figure 8) (30).  In the 
assembly experiments two different time-dependent pathways were observed. For those 
experiments that lasted 20 minutes a fast pathway was observed while a slow pathway 
was measured for longer incubation times (20-24 hours). The fast pathway went directly 
to assembled virions with a ratio of 90 homodimers of CP to one RNA molecule. In 
contrast, the slow pathway first formed a nucleoprotein structure, termed the C1 complex, 
in the presence of 10 CP dimers to one RNA molecule.  The actual stoichiometry and 
structure of this complex had not been investigated and is still not known. Once the C1 
complex was formed it was then followed by completion of the capsid shell. Folding of 
the RNA was observed to be independent of its own sequence but dependent on coat 
protein binding. The formation of the C1 complex was only observed in the slow 
pathway with gradual development over a six to eight hour period. Based on this data a 
model was proposed where coat protein first binds to the RNA with low cooperativity in 
the presence of excess RNA allowing the protein to find specific binding sites. The coat 
protein and RNA then fold to form the C1 complex although this is not observed via gel 
electrophoresis in the fast pathway due to the kinetics involved. Once the C1 complex is 
formed additional coat protein dimers can then be incorporated into the complex with 
high cooperativity (30). An initial site of nucleation has still not been identified for this 
virus although evidence does suggest that it is initiated with a pentamer of dimers of coat 
protein subunits instead of a hexameric structure (32, 33). 
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Figure 8. Proposed assembly path for CCMV. (1) CP initially binds excess RNA with 
low cooperativity allowing the CP to search for high-affinity binding sites. (2) CP and 
RNA slowly fold to form the C1 nucleoprotein complex which serves as a marker for 
RNA encapsidation. The complex forms in the presence of 10 CP: 1 RNA molecule 
although the actual stoichiometry and structure of the C1 complex is not known. (3) 
Addition of CPs to C1 is highly cooperative yielding complete virions (30). 
b. Bean Pod Mottle Virus (BPMV)
In contrast to CCMV, which is thought to initiate packaging by specific binding 
of a pentamer of coat proteins, crystallographic evidence of BPMV suggests an 
alternative mechanism. This virus belongs to the Comovirus family and contains a single-
stranded bipartite RNA genome where each RNA is encapsidated separately. Its capsid 
has pseudo T = 3 (P = 3) symmetry and is not a true icosahedron. The ability of the virus 
to form empty capsids and two different virions allowed for the comparison of 
contributing factors for assembly and stability. It was observed that 20% of the RNA 
packaged was structured while the remaining RNA on the interior of the virion not 
interacting with the coat protein was unstructured. From analysis of the electron density 
of both the empty capsids and complete virions it was determined that the coat proteins 
interact with a repeating sequence in the RNA. This sequence consists of six 
ribonucleotides: adenine, purine, pyrimidine, pyrimidine, pyrimidine, and X. Where X 
was defined as the base electron density at nucleotide position six consisting of only 
enough space for a five-membered ring. This sequence was found in both genomic RNAs 
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with a pyrimidine at nucleotide position six. Evidence suggests that the interactions 
between the bases and the amino acids are mediated by water molecules (see Figure 9). 
Figure 9. Bean pod mottle virus coat protein and RNA interactions. (a) Depicts trefoils of 
the genomic RNA within the capsid superimposed onto the electron density viewed from 
the exterior. (b) Represents the CP interacting with the RNA at the two-fold axis. The 
arrows indicate the CP and their N-termini in relation to the electron density of the RNA. 
(c) Interactions of the ordered RNA with the protein capsid (7). 
 
(a)
(b)
(c)
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The structure of the ordered genomic RNA for both virions was observed to be nearly 
identical indicating that both genomes contained the same RNA packaging signals. Since 
the CP can assemble without RNA the nucleic acid is not essential but the repeating 
sequence allows the genome to be targeted for assembly. Although it was determined that 
both genomes contain the same repeating sequence the actual RNA folding process is still 
unknown. According to a model proposed by Johnson the RNA first folds loosely 
obtaining an icosahedral geometry at which point the coat protein subunits, possibly 
pentamers, then assemble around it (7).   
3. TCV Assembly Model
Like CCMV, TCV has been used as model for studying icosahedral virion 
assembly. As a structural protein, the CP’s main function is assembly of the virion or 
encapsidation. The virus has been dissociated and reassembled in vitro and the process is 
most effective when assembling with the genomic RNA or RNA of an equivalent size 
(34, 35).  TCV incubated at pH 8.5 and 0.5 M salt dissociates into dimers and a 
ribonucleoprotein complex or RP complex, consisting of RNA and protein (8, 34). In 
1986 Harrison obtained the x-ray crystal structure at 3.2Å resolution and performed 
reassembly experiments in vitro from dissociated virions. From both of these studies a 
model of assembly was proposed although the evidence to support such a model is 
limited (4, 34). 
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According to the proposed model by Harrison (1986), the assembly process 
begins with the formation of a trimer of dimers that are connected by a -annulus 
structure in which the three ordered arms from the C subunits overlap. This complex was 
thought to form at a particular site on the TCV genomic RNA called the nucleation site 
(see Figure 10) (34). Interaction between the N-terminal R domain and the genomic RNA 
at the nucleation site, would facilitate the assembly process in vitro. Once a trimer of 
dimers is formed on the RNA the next dimer to add onto the complex adopts an A/B 
conformation with the existing CPs. The arrangement of these additional subunits 
prevents their R domain “arms” from folding and contributing to the established -
annulus. The formation of contacts between B and C faces lock in the extended arms 
from the complex around the -annulus. The overall assembly process consists of: (1) -
annulus formation by three dimers with C/C conformation and (2) dimers added onto the 
complex with A/B conformations. The “arm” between the S and R domains allows the 
CP subunits to arrange themselves into the proper configurations to form the capsid 
structure. Once the capsid starts to assemble more dimers are added cooperatively to 
complete the virus (34). 
 
This model was based on low resolution images of both the x-ray crystal structure 
of TCV and negatively stained samples from the in vitro reassembly experiments. The 
nature of the RP complex was proposed based on its size from gel-filtration of dissociated 
virions and the capsid structure from x-ray crystallography (4, 34). The presence of an RP 
complex was observed after gel-filtration, when samples were run on 
SDS/polyacrylamide gels. The RNA samples had a high molecular weight band that 
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would not load onto the gel but after ribonuclease A digestion the band was eliminated 
and a lower 38kDa band corresponding to CP was observed. This suggested that the 
observed high molecular weight band consisted of protein undissociated from the 
genomic RNA. From the intensities of the bands it was suggested that the composition of 
the RP complex was between five to six CP subunits per RNA molecule (34). The 
structure of the RP complex was not subjected to further characterization. The structure 
of the RP complex proposed in the model was based on the x-ray crystal structure 
arrangement of the CPs on each face of the virion. It was proposed that the C subunit 
“arms” would interlock to form a -annulus structure since it was previously known that 
the C conformational subunits were the only CPs with their “arms” in an ordered state 
and therefore the only subunits that could interact with the RNA. The actual -annulus 
structure has not been observed experimentally or in the crystal structure (4, 34). Since 
the in vitro reassembly experiment images supported the idea that the CP forms the 
capsid around the RNA then the first step proposed in the model was binding of a CP 
subassembly to the nucleation site on the genomic RNA. From the point of nucleation to 
completion of the capsid there is no experimental evidence from the in vitro reassembly 
experiments to support Harrison’s model (34). The sequential addition of the CP subunits 
described in the model is based primarily on the geometry of the final capsid itself (4). In 
summary, although a model has been proposed for TCV the only known evidence is that 
the CP binds to the RNA and then forms the capsid around it. The mechanism of the 
assembly process, including protein-RNA and protein-protein interactions has not been 
investigated further and is still unknown. Further experimentation needs to be carried out 
to better define the model of TCV assembly.          
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Figure 10. Assembly model of the TCV virion from re-assembled virions in vitro. (a) 
Formation of the RP complex consisting of a 6 CPs connected by the -annulus structure 
with the genomic RNA. (b) & (c) Continuation of assembly as described by the Harrison 
(1986) model (34). 
a. Initiation of TCV Assembly – Nucleation site
In order to initiate virion assembly the CP must first bind to a particular region on 
the genomic RNA, called the nucleation site. This region has been identified and 
characterized for other plant viruses. One classic example is that of Tobacco mosaic virus 
(see Figure 4) (19). According to Harrison’s (1986) TCV model the CP initiates assembly 
by binding to the nucleation site and forming the RP complex. Once bound to this region 
assembly can progress to completion (34). 
(a)
(b)
(c)
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In 1990 the RP complex was isolated and digested with both RNase A and RNase 
T1. Five fragments, Fa to Ff, from the TCV RNA genome protected from the digestion 
were isolated and identified. The fragments clustered in two regions: Ff, Fa and Fc were 
found in a ~400 nt region that included the leaky stop codon in the polymerase gene 
while Fe and Fd were located in the CP gene near the 3' end (36). Morris (1995), 
performed binding studies with the 386 nt region, containing Ff, Fa and Fc, of the 
genomic RNA and determined that the CP had no specificity for this region of the RNA 
(37). The fragments Fe and Fd were later tested using a protoplast infection assay in 
which mutant viral RNA assembly was examined. A region of 186 nt, containing a part 
of Fd, near the 3' end of the CP gene was found to be important for packaging. This 
region contained a 28 nt bulged hairpin loop, nt 3755-3791, that was essential for virion 
formation (see Figure 11) (35). Although this region has been identified, there have been 
no binding measurements published on the proposed interaction between this nucleation 
site and the viral CP. 
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Figure 11. This is a representation of the proposed nucleation site on the TCV genome 
(35). 
D. Introduction into the plant – virus-induced gene silencing (VIGS)
The level of assembly of the TCV virions has been correlated with symptom 
modulation. As the virion formation decreases in the cell there is an observed increase in 
the plant’s symptoms and a decrease in the gene silencing (38, 39). It has been indicated 
that even though the TCV CP is the main structural component of the assembled virion it 
also can contribute toward other functions including inhibition of gene silencing in the 
plant (16). 
bulged hairpin 
loop from 3755 
to 3791 nt.
CAA
UAA
CUGAG      GC       GC   AA          G
GACUC      CG        CG  UU          U
GA
 A
  A
AAA
C AGG
AAA
3752
3794
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RNA-induced gene silencing is a RNA degradation mechanism, which acts as a 
host response to the presence of double-stranded foreign RNA (see Figure 12) (40). It has 
been found to occur in animals, fungi and plants and is termed accordingly, RNA-
interference or RNAi, quelling, and post-transcriptional gene silencing or PTGS. The 
process can be triggered by the introduction of dsRNA, viral RNA, and/or single-stranded 
hairpin RNA into the plant cell. In the case of an infecting virus, TCV, its viral genomic 
RNA secondary stucture, dsRNA, triggers the RNA-induced gene silencing mechanism 
also known as virus induced gene silencing (VIGS). Once the dsRNA is introduced into 
the plant it is degraded into fragments 21-24 nucleotides in length called small interfering 
RNAs or siRNAs. During this step dsRNAs are cleaved by DICER or a DICER-LIKE 
homologue (DCL), a ribonuclease III-like enzyme which is ATP dependent (40). Dicer 
was originally discovered as the enzyme involved in RNAi in Drosophila (41). The 
specific RNase responsible for siRNA production in plants has not yet been identified, 
although there are four known DCLs in Arabidopsis (40). In Arabidopsis thaliana, DCL2 
participates in viral siRNA production (42). In the case of Dicer, the enzyme is a dimer 
when bound to the RNA allowing it to cleave on either side of its position on the dsRNA 
(43). The siRNA is then incorporated into the RNA-induced silencing complex known as 
RISC, consisting of both Dicer/DCL and the siRNA. In the presence of ATP RISC 
becomes activated and unwinds the double-stranded siRNA associated with the complex. 
Using a single-strand of the siRNA it can detect and recognize the viral RNAs 
complementary to its sequence, at which point the complex can degrade additional 
RNAs. At this point, the degradation process is independent of the dsRNA that initiated 
the gene silencing (40). 
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Figure 12. Schematic representation of the RNA-induced gene silencing mechanism in 
plants, indicating at which point TCV CP acts as a suppressor of the pathway (16, 40). 
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1. The viral counter-defense mechanism – TCV CP as a suppressor of VIGS
Since plants have mechanisms against viral infection it is only natural that viruses 
have evolved counter-defense mechanisms. There have been a number of studies 
performed in the last decade describing viral proteins that exhibit suppression activity 
against the silencing pathway. Each case is unique in that each identified protein targets a 
different step in the mechanism (see Figure 13). The Cucumber mosaic virus (CMV) 2b 
protein was one of the first to be studied and it was found to block the movement of the 
silencing signal, although how it can inhibit systemic silencing is still in question (40). 
The Potato virus X (PVX) p25 protein required for cell-to-cell movement has been 
implicated in an initiation step possibly interfering with the cellular RdRp so that the 
single-stranded RNA cannot be converted to double-stranded RNA (44). Another 
example is the helper-protease component (HC-Pro) of the Tobacco etch virus (TEV), 
which is thought to interfere in a maintenance step blocking the production of siRNAs of 
a certain size (45, 46). Although these suppressors have been identified their mode of 
action is still not well understood from a mechanistic viewpoint. One exception is the 
tombusviruses p19 protein that was found to bind to siRNAs in vitro, suggesting that the 
protein was binding and sequestering the siRNAs from RISC (47). In 2003 the crystal 
structure of the p19 from Carnation Italian ringspot virus (CIRV) bound to a 21 
nucleotide siRNA was reported to 2.5 Å resolution (48). This structure supported the idea 
that the protein acts to sequester specific siRNAs but it is still unclear if this function 
would occur in vivo.
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In recent studies, it has been observed that the TCV CP can also act as a 
suppressor of VIGS. It has been found that the TCV CP interferes early in the initiation 
step when Dicer degrades the dsRNA into siRNAs (see Figure 12). The exact mechanism 
of this suppression is not known (16).  In Arabidopsis thaliana, the CP has been proposed 
to interact with the DCL2 but not DCL1 enzymes (42, 49). It has been speculated that the 
N-terminal 25 amino acids of the coat protein R domain may contribute to the 
suppression activity of VIGS (17). This region interacts with the genomic RNA during 
assembly and may have an effect on dicer’s function. This suggests that it is the 
unassembled CP with free N-termini that participates in the suppression of VIGS.
Figure 13. This schematic representation of the VIGS pathway depicts the steps at which 
each suppressor is proposed to interfere (16). 
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2. TCV Subviral RNAs
The TCV CP can act as a suppressor of gene silencing in the plant only under 
particular conditions. Suppression has been observed when there is free CP in the cell not 
being used in the assembly pathway. The levels of free CP in the plant can be increased 
either by Agrobacterium co-infiltration or the presence of subviral RNAs, specifically 
satellite RNA C (39, 40). 
 
Viruses can be associated with subviral RNAs, which consist of defective 
interfering RNAs (DI RNAs) and satellite RNAs (satRNAs). While DI RNAs are 
common among animal viruses but rarely found with plant viruses, satRNAs are found 
specifically with plant viruses. DI RNAs are generated via a sequence of errors during 
replication and as a result can contain a high degree of sequence similarity with the 
helper virus. By contrast, satRNAs usually share little if any sequence similarity to the 
helper virus (50). An exception to this is the production of satC in the TCV infection 
process (38). 
 
During replication, satC is produced via a recombination event between satD and 
two discontinuous segments of the TCV genome. SatC is a chimeric molecule with 189 
bases of satD at its 5' end and the two TCV segments, totaling 166 bases, at its 3' end (see 
Figure 14). Since it shares the same 3' sequence with the genomic RNA it can also be 
replicated by the viral RNA-dependent RNA polymerase (RdRp) (38). 
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Figure 14. Depicts the TCV genomic RNA relative to both satD and satC. The satC is a
chimeric molecule consisting of satD at the 5' end and two segments of the TCV genomic 
RNA (#3764-3779 & #3900-4045) at the 3' end. 
3. TCV SatC & symptom modulation
Subviral RNAs can participate in symptom modulation, either by attenuation or 
exacerbation of symptoms. The addition of satC in the TCV infection has been observed 
to cause (1) a reduction in TCV virion accumulation (2) exacerbation of symptoms in the 
plant and (3) reduced gene silencing (see Figures 15 & 16) (38, 39). 
TCV   (4054 b)
sat D   (194 b)
sat C    (356 b) 40543779/3900
3764
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Figure 15. (a) Symptoms of Arabidopsis plants inoculated with TCV with (TCV + C) and 
without satC. The plants in the top row were photographed at 14 days postinoculation 
(dpi) and those in the bottom row were photographed at 21 dpi. Those plants labeled 
“Mock” were only treated with infection buffer alone. The plants infected with TCV 
show mild stunting and delayed bolting. Plants infected with TCV and satC show 
intensification of symptoms with plant death by 21 dpi. (b) Arabidopsis protoplasts were 
infected with TCV with (TCV + C) and without satC. The genomic RNA and satRNAs 
were detected by RNA gel-blot analysis while the CP and virions were detected using the 
anti-TCV CP antibody (39).  
Figure 16. Model for symptom modification by satC. The ds RNA regions in satC and 
TCV induce VIGS. Since unassembled CP is a suppressor of VIGS, a high level of CP 
combined with a low level of virions results in an increase in virus movement and thus 
severe symptoms (38).  
 
14 dpi
21 dpi
TCV gRNA
satC
CP
Virions
(a) (b)
Low CP, low virions
High CP, high virions
High CP, low virions
Low CP, low virions
High CP, low virions
TCV
TCV + satC
Mild/ none
Severe 
Moderate
Moderate
Severe 
SymptomsVIGS
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Previous studies have indicated that the CP does not have a binding affinity for 
the 3' end of satC, although this region is important in symptom modulation (51). 
Recently an internal plus-strand hairpin of satC, the M1H, which brings together flanking 
CA-rich sequences, has been found to increase satC fitness and reduce virion 
accumulation (52). How it may interfere with virion formation is not known. Although 
this hairpin does contain a segment of the sequence found in the essential packaging 
element of the TCV genome, its ability to reduce virion formation is sequence-
nonspecific (see Figure 17) (53). 
 
Figure 17. The M1H (+)-strand internal hairpin. The hairpin consists of the 3 end of 
satD, 16 bases from the TCV CP coding region and the 3' untranslated region of the TCV 
genome. The segment corresponding to part of the putative nucleation site is indicated 
above. Sequences labeled in blue are the original sequences and asterisks denote position 
differences with wt satC (53). 
satD  5'  CGAAAGAGUCCAAGACCCUGCCC - 3'
satC  5'  CAAAAGAAUCCCAGACCCU . . CCAGCCAAAGGGUAAAU  GGGACCAAAAA  3'
TCV      GAAAAUGGUCACAACUGAGGAGCAGCCAAAGGGUAAU/ GGGACCAAAAA
               *               *         *                     **
M1H
3779/ 3900
satC M1H (+)-strand
Part of 
nucleation site
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E. TCV Hypothesis
It has been previously theorized that satC interacts with the CP to disrupt the 
assembly process and thereby increase the amount of free CP in the plant. An increase in 
the amount of free CP early on in the infection process has been linked to systematic 
spread of the virus and exacerbation of symptoms already present. Even so, satC will not 
produce symptoms in plants that are already tolerant (39). The increased levels of free CP 
resulting from inhibition of virus assembly by satC, allows increased suppression of 
VIGS at the initiation step (see Figure 18) (16, 38). As a result the viral RNA is not 
degraded and the virus is still able to replicate and move throughout the plant.
Figure 18. A flow-chart representation of the Hypothesis describing the two functions of 
the CP. The red box highlights the CP as a suppressor of VIGS while the blue box 
highlights its ability to form virions.
In order to test the first part of the hypothesis, which proposes that satC interacts 
with the CP to inhibit virus assembly, a large quantity of recombinant CP from E. coli
must be obtained and its ability to assemble in vitro quantified. An in vitro assembly 
CP
genomic 
RNA
Virions
Sat RNA C VIGSSuppressor
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assay that allows for the observation of the complete assembly process including 
intermediates needs to be developed so that inhibition of assembly by satC can be 
measured. If it is determined that satC directly inhibits virion formation in vitro, 
experiments can be performed between CP and satC allowing for the identification and 
characterization of all RNA-protein interactions relevant to this inhibition. In this thesis 
the TCV coat protein gene has been cloned and the recombinant protein expressed and 
purified from E. coli. It has also been characterized for future use in the assembly assay. 
F. Overview Statement
Chapter 1, the Introduction, provides background on both viruses in general and 
specifically TCV in regards to virion structure, assembly and virus induced gene 
silencing in plants. The objective of this thesis research was to clone the CP gene and 
express, purify and characterize the TCV CP from E. coli in order to perform assembly 
experiments in vitro. This was done as foundation work so that the satC and CP 
hypothesis could be tested in vitro in the future.
G. Research Justification
Before the assembly mechanism can be investigated the coat protein had to first 
be characterized with respect to its folded conformation and assembled state in solution 
under different conditions, monomer, dimer, ect. All previous in vitro experiments with 
TCV have used the CP produced from either infected plants or protoplasts. In order to 
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attempt characterization using methods such as analytical ultracentrifugation, circular 
dichroism and other biophysical techniques, a large amount of protein is required. 
Extracting the CP from virions in the original manner requires both time and a large 
quantity of infected material since the virus must first be recovered from plant tissue 
before the CP can be extracted. It can take an inoculated plant on the average 2-3 weeks 
before symptoms emerge and infected leaves can be harvested for viral 
extraction/purification. Once infected leaves have been harvested the virus must first be 
extracted and purified before it can be dissociated. After dissociation of the virus the CP 
has to be separated from the genomic RNA, residual nucleic acids, and purified before 
experimental use. Since the coat protein cannot be directly purified from the leaf tissue 
the probablilty that a large yield of protein comparable to the original concentration 
present in the tissue can be recovered after the purification steps is low. During 
purification, with each additional step protein can be lost. According to Morris (1995), 
overall CP recovery from virions is about 40% (37). 
The original method takes an extensive amount of time and labor for the amount 
of protein recovered. Therefore, a different method of large-scale purification of TCV 
coat protein had to be devised. It consisted of cloning the CP coding sequence, expressing 
the protein in an E. coli strain and devising a purification procedure that allowed the 
protein to be produced within a short time period and in quantities appropriate for future 
biophysical experimentation, including assembly experiments. In the future specific 
mutants of the CP can also be generated easily via this method. This will allow 
investigation of interactions between the CP, genomic RNA and satC.
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II. Experimental
Chapter II describes all the materials and methods used in this research. It 
includes all methods associated with the cloning of the TCV CP coding sequence and 
expression, purification and characterization of the recombinant coat protein. The 
techniques used to obtain purified virions and CP from infected plant tissue, images of 
the virions and the synthesis/purification of the TCV genomic RNA are also discussed in 
detail.
A. Plasmid Constructs
The full-length TCV- MS genomic DNA sequence inserted into a pUC19 plasmid 
was obtained from Anne Simon’s lab (University of Maryland, Department of Cell 
Biology and Molecular Genetics). The CP coding sequence was amplified using 
polymerase chain reaction (PCR) with a MasterAmp Taq DNA polymerase kit (Epicentre 
Biotechnologies). The 50 µL PCR reaction contained 1 x PCR enhancer, 3 x PCR buffer, 
200 µM of each dNTP, 2.5 mM MgCl2, 1 ng/µL TCV plasmid template, 0.6 µM of each 
oligo, and 1 µL Taq DNA polymerase enzyme. The CP N-terminal oligo sequence 5' –
CAA CAC ATA AGC ATC AAC ACT GCA TAT GGA AAA TGA TCC TAG AG  3' 
contained the Nde I cleavage site while the C-terminal oligo sequence 5' – GAG AAG 
ACT ACA CAG GAT CCG TAC TAA ATT CTG AGT GCT TGC  3' contained the 
BamH I cleavage site (see Figure 19). 
39
CA
A
 CA
C
 A
TA
 A
G
C
 A
TC
 A
A
C
 A
CT
 G
CA
 TA
T
 G
G
A
 A
A
A
 TG
A
 TCC
 TA
G
 A
G
5
' 
–
–
3'
N
-T
erm
in
al
 O
lig
o
N
de
 I
–
3'
G
A
G
 A
A
G
 A
C
T
 A
CA
 CA
G
 G
A
T
 CCG
 TA
C
 TA
A
 A
TT
 CTG
 A
G
T
 G
CT
 TG
C
5
' 
–
C
-T
erm
in
al
 O
lig
o
B
am
H
I
Fig
u
re
 19. The
 sequen
ces
 of
 the
 olig
o
s
 u
sed fo
r
 am
plificatio
n
 of
 the
 C
P
 g
en
e
 are
 show
n
 w
ith the
 restrictio
n
 
en
zy
m
e
 cleav
ag
e
 sites
 indicated.
CA
A
 CA
C
 A
TA
 A
G
C
 A
TC
 A
A
C
 A
CT
 G
CA
 TA
T
 G
G
A
 A
A
A
 TG
A
 TCC
 TA
G
 A
G
5
' 
–
–
3'
N
-T
erm
in
al
 O
lig
o
N
de
 I
–
3'
G
A
G
 A
A
G
 A
C
T
 A
CA
 CA
G
 G
A
T
 CCG
 TA
C
 TA
A
 A
TT
 CTG
 A
G
T
 G
CT
 TG
C
5
' 
–
C
-T
erm
in
al
 O
lig
o
B
am
H
I
CA
A
 CA
C
 A
TA
 A
G
C
 A
TC
 A
A
C
 A
CT
 G
CA
 TA
T
 G
G
A
 A
A
A
 TG
A
 TCC
 TA
G
 A
G
5
' 
–
–
3'
N
-T
erm
in
al
 O
lig
o
N
de
 I
CA
A
 CA
C
 A
TA
 A
G
C
 A
TC
 A
A
C
 A
CT
 G
CA
 TA
T
 G
G
A
 A
A
A
 TG
A
 TCC
 TA
G
 A
G
5
' 
–
–
3'
N
-T
erm
in
al
 O
lig
o
CA
A
 CA
C
 A
TA
 A
G
C
 A
TC
 A
A
C
 A
CT
 G
CA
 TA
T
 G
G
A
 A
A
A
 TG
A
 TCC
 TA
G
 A
G
5
' 
–
–
3'
N
-T
erm
in
al
 O
lig
o
N
de
 I
–
3'
G
A
G
 A
A
G
 A
C
T
 A
CA
 CA
G
 G
A
T
 CCG
 TA
C
 TA
A
 A
TT
 CTG
 A
G
T
 G
CT
 TG
C
5
' 
–
C
-T
erm
in
al
 O
lig
o
B
am
H
I
–
3'
G
A
G
 A
A
G
 A
C
T
 A
CA
 CA
G
 G
A
T
 CCG
 TA
C
 TA
A
 A
TT
 CTG
 A
G
T
 G
CT
 TG
C
5
' 
–
C
-T
erm
in
al
 O
lig
o
B
am
H
I
G
A
G
 A
A
G
 A
C
T
 A
CA
 CA
G
 G
A
T
 CCG
 TA
C
 TA
A
 A
TT
 CTG
 A
G
T
 G
CT
 TG
C
5
' 
–
C
-T
erm
in
al
 O
lig
o
B
am
H
I
Fig
u
re
 19. The
 sequen
ces
 of
 the
 olig
o
s
 u
sed fo
r
 am
plificatio
n
 of
 the
 C
P
 g
en
e
 are
 show
n
 w
ith the
 restrictio
n
 
en
zy
m
e
 cleav
ag
e
 sites
 indicated.
40
The PCR protocol used was as follows; the first stage was 5 minutes at 94°C, the second 
stage was 30 cycles at 94°C 1 minute, 43°C 1 minute and 72°C 2 minutes and the third 
stage was 1 minute at 72°C with the reaction being held at 4°C upon completion. The 
complete PCR reaction was loaded onto an agarose gel, the band corresponding to 
product was excised and the TCV CP DNA eluted via electrophoresis. The DNA was 
then ethanol precipitated, resuspended in TE buffer containing 10 mM Tris-HCl, 1 mM 
EDTA pH 8.0, ligated into a pGEM-T Easy PCR cloning vector (Promega), transformed 
into Top 10 cells and amplified in vivo. The insert was excised from the purified plasmid 
with the restriction enzymes Nde I and BamH I (New England BioLabs) and ligated into 
the Novagen bacterial expression vector pET-17xb that confers ampicillin resistance. 
This pET-17xb/TCV CP plasmid was transformed into the E. coli cell strain 
BL21(DE3)pLysS, amplified in vivo and the DNA recovered and purified for 
sequencing (see Figure 20A; Anne Colgrove and Beckett unpublished). 
CP DNA purified from eight different isolates was subjected to DNA sequencing 
(DNA Sequencing Facility operated by the Center for Biosystems Research at the 
University of Maryland College Park Campus). The sequencing data was analyzed using 
the sequence alignment program LALIGN found on the ExPASy website, Expert Protein 
Analysis System proteomics server of the Swiss Institute of Bioinformatics 
(www.expasy.org), by comparing the sequences to both coat protein coding sequences 
MS and B of TCV. The difference in the two CP DNA sequences exists at the genome 
positions 209, 371 and 1037, which code for the amino acids S70, A124 and L346 for 
TCV-B and T70, V124 and W346 for TCV-MS, respectively (see Figure 21). Upon 
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analysis of the sequencing data it was observed that all of the isolates contained 
numerous silent and missense mutations. By comparing the sequences it was determined 
that the two isolates #1 and #8 could be digested with the restriction enzymes HinD III 
and BsaA I (New England BioLabs) and one fragment from each ligated together to 
decrease the overall number of missense mutations in the full CP gene (1056 nt) to only 
three. The two isolates were cut with these restriction enzymes HinD III and BsaA I, for 
which each enzyme only had one cleavage site on the plasmid. A 612 nt fragment from 
isolate #1 was ligated to a 443 nt fragment from isolate #8 in an effort to form a sequence 
with the least number of missense mutations (see Figure 20B). These three mutations 
were then corrected by site-directed mutagenesis using Stratagene’s Quick-change site-
directed mutagenesis kit and the amplified DNA re-sequenced (see Figure 22). The 
protein parameters including molecular weights and theoretical isoelectric points were 
calculated using the ProtParam program also found at the ExPASy website. The TCV 
CP-MS extinction coefficient used for CP-MS concentration determination was 
calculated based on its amino acid sequence (54). 
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B. Induction tests for pET-17xb/TCV CP-MS and B transformed into E. coli strains
1. Strains BL21(DE3) and BL21(DE3)pLysS
Both coat protein MS and B coding sequences inserted into the Novagen pET-
17xb plasmid were originally transformed into two E.coli cell lines BL21(DE3) and 
BL21(DE3)pLysS. These transformants were plated on LB/ 100 µg/mL ampicillin 
plates and a colony from each was grown in a 5 mL volume of LB/ 100 µg/mL ampicillin 
media. Induction tests were performed with these cultures to determine which yielded the 
highest CP expression level. A 5 mL culture of each was grown at 37°C, shaking at 300 
rpm until the OD600 was ~0.9. At this point a 1 mL sample was transferred to a new 
culture tube and the expression of the CP in the remaining sample was induced by adding 
IPTG to a final concentration of 75 µg/mL. All cultures were incubated at 37°C for a 
remaining one to two hours shaking at 300 rpm after which 500 µL samples of both the 
uninduced and induced cultures were removed for analysis on SDS-polyacrylamide gels.
2. Strain BL21(DE3)
Induction tests of 50 mL with varying incubation temperatures and induction 
times were performed with both pET-17xb/TCV CP plasmids transformed into the 
BL21(DE3) cell line. Four 50 mL cultures were grown for each transformant with 
growth temperatures of 37°C 30°C, 25°C, and 20°C respectively. At an OD600 of ~0.9 
two mL from each were removed and placed into corresponding tubes labeled uninduced 
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while the expression of the CP in the remaining 48 mL was induced by addition of IPTG 
to a final concentration of 75 µg/mL. Both the uninduced and induced cultures continued 
to grow at the same initial temperature for a total of four hours with a 500µL sample 
removed from the induced culture at each hour past the time of induction. An uninduced 
sample was removed at the four-hour mark. All samples were analyzed on SDS-
polyacrylamide gels to determine the level of expression in relation to the induction time 
and temperature.
An induction test was performed for the pET-17xb/TCV CP-MS plasmid 
transformed into the BL21(DE3) cell line grown at 25°C varying the initial OD600 and 
length of the induction. Initially a 200 mL culture was grown at 25°C on the shaker at 
300 rpm with the OD600 measured every 20 minutes. When the cell density reached 
OD600s of 0.5, 0.6, 0.7, 0.8 and 0.9, a culture volume of 25 mL was removed. The 
expression of the CP was induced in each of these samples by addition of IPTG to a final 
concentration of 75 µg/mL. The induced cultures continued to grow at the same initial 
temperature for a total of five hours with a 500µL sample removed from the induced 
culture at each hour past the time of induction. A sample was taken from the uninduced 
culture at the five-hour mark. All samples were analyzed on SDS-polyacrylamide gels to 
determine the level of expression in relation to the OD600 at induction and the length of 
the induction.
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3. Strain Rosetta(DE3)
The recombinant plasmid pET-17xb/TCV CP-MS was transformed into the E.coli
cell line Rosetta(DE3). The transformants were plated on LB/ 100 µg/mL ampicillin/ 20 
µg/mL chloramphenicol plates and a colony from each was grown in a 5 mL volume of 
LB/ampicillin/chloramphenicol media. Induction tests were performed to determine the 
CP expression level at different growth temperatures. A series of 5 mL cultures were 
grown at either 37°C or 25°C with shaking at 300 rpm, until the OD600 was between 0.6 
to 0.9. At this point a 1 mL sample was transferred to a new culture tube and the 
expression of the CP in the remaining sample was induced by the addition of IPTG to a 
final concentration of 75 µg/mL. All cultures were incubated for a remaining one to two 
hours at the corresponding temperature with shaking at 300 rpm after which 500 µL 
samples of both the uninduced and induced cultures were removed for analysis on SDS-
polyacrylamide gels.
C. Protocol for Expression and Purification from BL21(DE3)
1. Expression of Recombinant TCV CP (500 mL protein preparation trial)
E.coli strain BL21(DE3) was freshly transformed with the pET-17xb/TCV CP-
MS plasmid and grown in LB media containing 100 µg/mL ampicillin with shaking at 
300rpm either at 30°C, 25°C or 20°C. Once the cell density achieved an OD600 of ~0.9 
expression was induced by adding IPTG to a final concentration of 75 µg/mL. Once it 
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was determined that a growth temperature of 25°C with an induction time of four hours 
was ideal, the protocol was altered so that the OD600 was 0.7 to 0.8 before the cells were 
induced. After a 4 hour induction period cells were harvested by centrifugation at 7,500g
for 20 minutes at 4°C. A 500 µL sample of the uninduced and induced cultures were 
taken for future protein identification using SDS-PAGE gel electrophoresis.
2. Sonication of Cells 
The pellet containing the harvested cells was resuspended in 100 mL of lysis 
buffer containing 100 mM sodium phosphate pH 6.5, 200 mM NaCl, 5% (v/v) glycerol 
and 0.1 µM DTT, pelleted by centrifugation at 7,500g for 20 minutes at 4°C and 
resuspended in 50 mL of lysis buffer containing 0.1 mM DTT and 0.1 mM PMSF. The 
resuspended pellet was transferred to a stainless steel 125 mL beaker and put on an ice-
salt bath. Once the solution temperature was below 4°C the cells were subjected to 
sonication, using 30 second bursts and cooling to <4°C between bursts, until the OD600
was less than one-tenth the original value. Cells were then diluted to 200 mL with lysis 
buffer, 0.1mM DTT, 0.1mM PMSF and centrifuged at 12,000 rpm for 45 minutes at 4°C 
using a SLA-1500 rotor (Sorvall). The resulting pellet was resuspended once in 24.5 mL 
of lysis buffer, 0.1 mM DTT, 0.1 mM PMSF and another sample was removed for SDS-
PAGE gel analysis.
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3. Guanidine-HCl Extraction   
The method for extraction of insoluble protein using guanidine-HCl was modified 
from a protocol in Current Protocols in Protein Science (55). The resuspended post lysis 
pellet was centrifuged at 22,000g for 1 hour at 4°C. The resulting pellet containing the 
inclusion bodies was washed twice with 25 mL wash buffer containing 100 mM Tris-HCl 
pH 7.0 at 4°C, 5 mM EDTA, 5 mM DTT, 0.1 mM PMSF, and supplemented with 2 M 
urea and 2% (v/v) Triton X-100. The urea and Triton X-100 solubilized proteins were 
removed by washing the pellet once in 25 mL wash buffer only. After each pellet 
resuspension, the solution was centrifuged at 12,000 rpm for 30 minutes at 4°C using a 
SLA-1500 rotor. The washed inclusion bodies were then solubilized in 5 mL of 
extraction buffer containing 50 mM Tris-HCl pH 7.0 at 4°C, 5 mM EDTA, 8 M 
guanidine-HCl, and 5 mM DTT. A 1 mL volume of buffer was added per half gram of 
wet cells. Insoluble material was removed by ultracentrifugation at 29,000 rpm for 1 hour 
at 4°C using a Beckman 70.1 Ti rotor. The supernatant was then collected and filtered 
through a 0.22µM filter and stored at 4°C for purification.
4. Urea Extraction   
The urea extraction procedure was similar to the guanidine-HCl method except 
for some changes in the buffers. The wash buffer now contained 1 M Tris-HCl, 50 mM 
EDTA, 100 mM NaCl, pH 8.0 at 4°C with 1 mM DTT and 0.1 mM PMSF added 
immediately before use. It was also supplemented with 2 M Urea and 2% Triton X-100. 
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The extraction buffer contained 50 mM Tris-HCl, 5 mM EDTA, 8 M Urea, pH 8.0 at 4°C 
and 10 mM DTT. After extraction the solution was centrifuged at 12,000 rpm for 30 
minutes at 4°C using a SLA-1500 rotor (Sorvall) instead of at 29,000 rpm for 1 hour at 
4°C using a Beckman 70.1 Ti rotor. 
5. Purification of recombinant TCV CP
a. Guanidine-HCl Purification Methods 
The gel-filtration chromatography and dialysis was modified from a protocol in 
Current Protocols in Protein Science (55). Chromatography was performed under 
denaturing conditions in the case of gel-filtration. A variety of different resins were tested 
including Sephacryl S-200 (Amersham Biosciences) and Sephacryl S-1000SF 
(Amersham Biosciences). The filtered guanidine-HCl solubilized protein was loaded onto 
a packed column approximately 1.5 by 50 cm with a bed volume of about 80 mL, 
previously equilibrated with about 2 column volumes of gel-filtration buffer containing 
50 mM Tris-HCl pH 7.5, 4 M guanidine-HCl and 5 mM DTT. The sample was then 
eluted with an additional two column volumes of gel-filtration buffer. Fractions (~3 to 4 
mL each) were collected every 10 minutes at a flow rate ~0.35 mL/min. The fractions 
containing protein were detected by absorbance at 280nm, checked on 12.5% SDS 
polyacrylamide gels, and then pooled and stored at 4°C.
The protein was renatured by removing the guanidine-HCl and DTT in a step-
wise dialysis procedure. The protocol included four 1 hour dialysis steps performed 
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against high salt buffer containing 10 mM Tris-HCl, 1 M NaCl, 0.1 mM EDTA, 5% (v/v) 
glycerol, pH 8.0 at 4°C with 1, 0.6, 0.2, and 0 M guanidine-HCl respectively. All dialysis 
steps were performed at 4°C. The protein concentration was determined via spectroscopic 
measurements at 280 nm using the TCV CP-MS calculated extinction coefficient of 
57280 M-1cm-1 (54).   
b. Urea Purification Methods 
Chromatography followed a protocol based on a method by the Stanley Lab (56). 
A CM Sepharose column (Amersham Biosciences) was run under denaturing conditions 
with solutions containing urea. All solutions were made fresh and used immediately since 
urea decomposition leads to cyanate production. Tris-base was added to all buffers to act 
as a cyanate scavanger. The filtered solubilized protein was applied to a packed CM 
Sepharose column of 1.5 x 30 cm with a bed volume of ~ 40 mL, previously equilibrated 
with column buffer containing 50 mM Tris-HCl, 5 mM EDTA, 8 M urea, pH 8.0 at 4°C 
and 10 mM DTT.  The column was then washed with 5 column volumes of column 
buffer at a flow rate of ~ 0.35 mL/min. to remove any protein contaminants that did not 
bind. Bound material was then eluted with a linear 0 M to 1.0 M NaCl gradient using 5 
column volumes at a flow rate of ~ 0.35 mL/min. Fractions were collected at 10 minute 
intervals (3.5 mL each) and those containing protein detected by absorbance at 280 nm, 
checked on 12.5% SDS polyacrylamide gels, and then pooled and stored at 4°C. 
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D. Protocol for Expression and Purification from Rosetta (DE3) strain
1. Expression of Recombinant TCV CP (500 mL protein preparation test)
E. coli strain Rosetta (DE3) cells from Novagen that were transformed with the 
pET-17xb containing the TCV CP DNA strain MS coding sequence were grown in LB 
media containing 10 g/L bacto tryptone, 5 g/L bacto yeast extract, 5 g/L NaCl, 1 mM 
NaOH, 0.02 g/L Chloramphenicol, 0.1 g/L Ampicillin at 25°C until the absorbance of the 
culture at 600 nm against uninoculated media was 0.7 to 0.8 Units. T7 transcription was 
then induced with the addition of isopropyl -D-thiogalactopyranoside (IPTG; 
FisherBiotech) to a total concentration of 75 µg/mL. After a 4 hour induction period cells 
were harvested by centrifugation at 7,500g for 20 minutes at 4°C. A 500 µL sample of 
the uninduced and induced cultures were taken for future protein identification using 
SDS-PAGE gel electrophoresis.
2. Sonication of Cells
The method for the preparation of the harvested E. coli cells for sonication was 
modified from the Current Protocols in Protein Science (55). The pellet containing the 
harvested cells was washed with 100 mL lysis buffer containing 100 mM Tris-HCl, 5 
mM EDTA, 500 mM NaCl and 0.1 µM DL-Dithiothreitol (DTT; FisherBiotech). The 
cells were then pelleted by centrifugation and resuspended in 50 mL Lysis buffer, 0.1 
mM DTT, 0.1 mM phenylmethylsulfonyl fluoride (PMSF; Sigma), and 10 µM N-p-
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Tosyl-phenylalanine chloromethyl ketone (TPCK; Sigma). The resuspended pellet was 
transferred to a stainless steel 125 mL beaker and put on an ice-salt bath. Once the 
solution temperature was below 4°C the cells were subjected to sonication, using 30 
second bursts and cooling to <4°C between bursts, until the OD600 was less than one-
tenth of the original value. Cells were then diluted to 200 mL with lysis buffer, 0.1mM 
DTT, 0.1mM PMSF, 10 µM TPCK, and centrifuged at 22,000g for 45 minutes at 4°C 
using a SLA-1500 rotor (Sorvall) at 12,000 rpm. The resulting pellet was resuspended 
once in a 24.5 mL volume and another sample was removed for gel analysis. 
3. Urea Extraction of Inclusion Bodies
An inclusion body extraction method was modified from two different protocols 
published by the Stanley lab for the expression of the Human Papillomavirus Type 16 L1 
protein in E. coli and the Current Protocols in Protein Science for the preparation and 
extraction of insoluble protein from E. coli (55, 56). The resuspended post lysis pellet 
was centrifuged at 22,000g for 1 hour at 4°C. The resulting pellet containing the 
inclusion bodies was washed twice with wash buffer containing 100 mM Tris-HCl pH 8.0 
at 4°C, 5 mM EDTA, 100 mM NaCl, 1 mM DTT, 0.1 mM PMSF, and supplemented 
with 2 M urea and 2% (v/v) Triton X-100. The urea and Triton X-100 solubilized 
proteins were removed by washing the pellet once in wash buffer only. After each pellet 
resuspension, the solution was centrifuged at 12,000 rpm for 30 minutes at 4°C using a 
SLA-1500 rotor. The washed inclusion bodies were then solubilized in 5 mL of 
extraction buffer containing 50 mM Tris-HCl pH 8.0 at 4°C, 5 mM EDTA, 8 M urea, and 
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10 mM DTT. A 1 mL volume of buffer was added per half gram of wet cells. Insoluble 
material was removed by centrifugation at 22,000g for 30 minutes at 4°C. The 
supernatant was then collected and filtered through a 0.22µM filter and stored at 4°C for 
future purification steps.
4. Purification of TCV CP
Chromatography and dialysis followed a protocol based on a method by the 
Stanley Lab (56). A CM Sepharose column was run under similar denaturing conditions 
as described for the CP purification from the BL21(DE3) strain except for the 
following. The filtered solubilized protein was applied to a packed CM Sepharose 
column of 2.0 x 16 cm with a bed volume of 30 mL instead of 40 mL. Once the protein 
was bound to the column and washed, the bound material was eluted with a linear 0.025 
M to 0.25 M NaCl gradient using 13 column volumes at a flow rate of ~0.35 mL/min. 
Fractions were still collected at 10 minute intervals (3.5 mL each) and those containing 
protein detected by absorbance at 280 nm, checked on 12.5% SDS polyacrylamide gels, 
and then pooled and stored at 4°C. 
This purified protein was renatured by removing the denaturing agent and DTT in 
a step-wise dialysis procedure. Five 2 hour dialysis steps were performed against high 
salt buffer containing 50 mM Tris-HCl, 1 mM EDTA, 1 M NaCl, pH 8.5 at 4°C with 4.0, 
2.0, 1.0, and 0 M urea, respectively. Finally the protein was dialyzed once for 2 hours 
against high salt buffer containing 5% (v/v) glycerol. All the dialysis steps were 
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performed at 4°C. The protein concentration was determined by UV spectroscopy at 280 
nm with a calculated TCV CP-MS extinction coefficient of 57280 M-1cm-1. All dialyzed 
samples were then stored as aliquots at -70°C for further analysis and characterization.
E. Analytical Ultracentrifugation Experiments
Sedimentation velocity and equilibrium experiments were carried out in a 
Beckman Optima XL-1 analytical ultracentrifuge (Beckman Coulter, Fullerton, CA, 
USA) with an An 60 Ti rotor and absorption optics at 20°C. Purified stored TCV CP was 
thawed on ice and dialyzed against either high salt 1 M NaCl buffer, 0.5 M NaCl buffer 
or 0.25 M NaCl buffer containing 100 mM Tris-HCl, 5 mM EDTA, pH 8.5 at 20°C, in
order to remove all glycerol. Samples were then prepared by dilution into the appropriate 
dialysis buffer at different concentrations. 
Sedimentation velocity experiments were performed at speeds of 45,000 rpm and 
data collected at 280 nm. Absorbance scans were collected at intervals of 15 sec in 
replicates of three scans with a radial step size of 0.003 and a total of 100-300 scans were 
recorded per sample. Spectra were analyzed with the DCDT+ version 1.15 software (57). 
Raw data scans were loaded into the program and graphed allowing the meniscus to be 
set. The dc/dt values for each pair of scans were calculated and the corresponding graphs 
overlayed. The radial cutoff at the cell base was adjusted so that the curves did not 
exhibited negative spiking or ‘tails’ at the ends . The time range was then tested for 
excessive broadening. The number of scans included in the analysis was dependent on the 
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mass limit value. If this value was near to or less than the expected mass of any species in 
the sample the number of scans included in the analysis was reduced. Additional scans 
were added only when the mass limit value far exceeded the expected mass. Once an 
acceptable value was reached the average dc/dt was calculated and graphed. The upper 
and lower sedimentation coefficients for the range were set and used to calculate the 
g(s*) distribution. This was then fit to gaussians allowing the sedimentation coefficient 
and molecular mass for various species to be derived based on the specific model 
implemented in the analysis process (57). The buffer density, buffer viscosity, TCV CP 
partial specific volume (vbar) and all temperature corrections were calculated using the 
protein analysis program SedNTerp (John Philo, 6/2001). 
Sedimentation equilibrium experiments were made with rotation speeds of 
10,000, 20,000, 22,000 and 26,000 rpm and data collected at 280 nm. Absorbance scans 
were collected with a radial step size of 0.003 and in replicates of three. Samples were 
allowed to achieve equilibrium over the course of 18 hours and were determined to be at 
equilibrium by superimposing two scans collected 1 hour apart. The data were then 
analyzed with NONLIN software (58). 
 
F. Circular Dichroism Experiments
Circular dichroism (CD) measurements were recorded on a Jasco CD J-810 
spectrophotometer at 20°C, using a 0.1 cm path length cuvette. Samples were prepared 
with concentrations of 9-10 µM TCV CP in both sodium phosphate, Tris buffer 
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containing 100 mM NaH2PO4/Na2HPO4, 50 mM Tris-HCl, 1 mM EDTA, pH 8.5 at 20°C 
and sodium phosphate buffer containing 100 mM NaH2PO4/Na2HPO4 pH 8.5 at 20°C. 
Far UV spectra were collected from 180 nm to 250 nm. Data below 200 nm could not be 
analyzed due to buffer interference. Buffer absorbances were collected and subtracted 
from the samples before analysis, which was performed with the JASCO Spectra 
Manager program. Far UV CD values were reported in the form of AU (absorbance 
units). 
G. TCV Genomic RNA Synthesis 
The pUC19 plasmid containing the full-length TCV genomic DNA insert, 
obtained from Anne Simon’s Lab, was linearized by digestion with the restriction 
enzyme Sma I (New England BioLabs) and purified by phenol:chloroform extraction and 
ethanol precipitation before use as the reaction template. The TCV genomic RNA was 
synthesized using the MEGAscript kit (Ambion) with transcription of the TCV genomic 
DNA template by the T7 RNA polymerase. All synthesis and purification steps followed 
the MEGAscript kit instruction manual. The 20 µL reaction contained 2 µL of each 75 
mM ATP, CTP, GTP and UTP (7.5 mM final concentration), 2 µL 10 x Reaction buffer, 
1 µg linearized template DNA and 2 µL enzyme mix. It was then incubated at 37°C for 
about three hours. The synthesized RNA was purified by either lithium chloride 
precipitation or by a phenol:chloroform extraction followed by an ethanol precipitation. 
The lithium chloride precipitation solutions were provided in the kit. All other solutions 
used were prepared from diethyl pyrocarbonate (DEPC)-treated/autoclaved milli-Q 
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water. Tubes and pipet tips were purchased as nuclease-free (Ambion) and all other 
glassware/equipment was treated with RNase Away (Molecular Bioproducts) and rinsed 
with DEPC-treated/autoclaved milli-Q water.  For the ethanol precipitation and wash 
steps a 99.5% ACS grade ethanol reagent was used to decrease the amount of degradation 
observed in the samples. All synthesized RNA was resuspended in nuclease-free water 
before determining the absorbance at 260 nm and storing at -20ºC. For long- term storage 
RNA should be ethanol precipitated and stored at -70ºC. RNA samples were checked on 
formaldehyde-agarose gels to determine the size and efficiency of each step.    
H. Polyacrylamide and Agarose Gel Electrophoresis
1. SDS-PAGE Gels
The induction, extraction and purification samples of recombinant CP were 
monitored by 12.5 % SDS polyacrylamide gels (59). Induction samples were collected, 
pelleted, resuspended in sample buffer containing 0.0625 M Tris-HCl pH 6.8, 3% SDS, 
30% glycerol, 0.0125% Bromophenol blue with 5% (v/v) -mercaptoethanol and heated 
at 90°C for 10 minutes before loading. Urea extraction and CM Sepharose fraction 
samples at 8 µL each were added to 10 µL sample buffer with 5% (v/v) -
mercaptoethanol and heated as described previously. All samples were loaded on 12.5% 
polyacrylamide gels and run at 150 V to 250 V using running buffer containing 3 g/L 
Tris-base, 14.4 g/L Glycine, 0.1% SDS. Gels were then stained with Coomassie staining 
solution containing 4.6% acetic acid, 47.5% ethanol, 2.5 g/L coomassie brilliant blue R-
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250, for 1 hour, destained with destaining solution consisting of 4.6% acetic acid, 24% 
ethanol and then dried using the Invitrogen gel drying system. 
a. Guanidine-HCl sample treatment
All samples that contained guanidine-HCl had to be treated to remove the 
denaturant before loading onto polyacrylamide gels (55). For each 25µL sample, 225µL 
of cold ethanol was added, vortexed and stored at -20°C for 5 to 10 minutes. Once the 
protein had precipitated, the sample was microcentrifuged at 15,000g for 5 minutes at 
4°C. The supernatant was removed and the pellet washed once with 250 µL cold ethanol 
and microcentrifuged again. The resulting pellet was resuspended into 25 µL sample 
buffer as indicated above.
2. Formaldehyde-Agarose Gels
RNA samples were run on formaldehyde-agarose gels using an established 
protocol, to determine the efficiency of RNA synthesis and analyze the purification 
procedure (60). A 1% agarose-formaldehyde gel was prepared by dissolving 1g agarose 
into 72 mL DEPC-treated distilled water and cooling to 60°C in the water bath. Under the 
hood 10 mL of 10 x MOPS buffer, containing 0.4 M MOPS pH 7.0, 0.1 M sodium 
acetate and 0.01 M EDTA, and 18 mL formaldehyde were added. The gel was then 
poured and allowed to set at least 2 hours before use. Samples were prepared by adding, 1 
to 2 µL RNA to 2.5 µL 10 x MOPS buffer, 4.5 µL 37% formaldehye, 12.5 µL formamide 
and bringing the volume up to 25 µL with DEPC-treated distilled water. The samples 
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were then vortexed, centrifuged down and incubated 15 minutes at 65°C before adding 10 
µL loading buffer containing 1 mM EDTA pH 8.0, 0.25% (w/v) bromophenol blue, 
0.25% (w/v) xylene cyanol and 50% glycerol. After loading the gel under the hood the 
samples were electrophoresed in 1 x MOPS buffer at 80 V until the bromophenol blue 
had migrated two-thirds the way down the gel. The gel was then removed and stained in 
DEPC-treated water containing 0.5 µg/mL ethidium bromide. The protocol was modified 
with respect to the length of time for destaining in DEPC-treated/autoclaved milli-Q 
water. The destaining procedure was run overnight for best results. All solutions, tips, 
tubes and equipment were RNase free. 
3. Agarose Gel Electrophoresis of TCV 
Virion samples were run on 0.6% high strength agarose (USB) gels prepared with 
1 x TAE buffer containing, 40 mM Tris acetate, 2 mM EDTA pH 8.5, as described by 
both the Young and Zlotnick labs (30). All samples were mixed with loading buffer 
containing 30% glycerol, 0.25% bromophenol blue, and 0.25% xylene cyanol, before 
loading onto the gel. Once all samples were loaded into the appropriate wells the gel was 
electrophoresed at 60V in 1 x TAE buffer until the bromophenol blue band had migrated 
two-thirds the way down the gel. It was then stained for 5 minutes in 5 µg/mL ethidium 
bromide, destained overnight in distilled water and visualized under a UV light. 
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J.  Virus and CP Purification from plant tissue
1. Plant growth and virus inoculation
Turnip plants were grown in growth chambers at 20°C as described previously by 
the Simon lab (51). At least thirty-three turnip seedlings were required per inoculation 
with three seedlings as the control group. Seedlings with at least four leaves were 
transplanted into sterile pots with three plants per pot and were incubated in a growth 
chamber. All plants were watered 24 hours before inoculation and the leaves cleaned of 
any soil. Those seedlings with four to six leaves were mechanically inoculated. The two 
oldest leaves on each plant were inoculated with 10 µL inoculation solution containing 
1µg TCV genomic RNA per leaf. The pUC19/TCV plasmid cleaved with the restriction 
enzyme Sma I was used as the DNA linear template for synthesis of the TCV genomic 
RNA. The RNA was synthesized at 37°C for 3 hours in a 100 µL reaction volume 
containing 3 µL 1 M Tris-HCl pH 8.0, 16.5 µL 150 mM MgCl2, 2 µL 100 mM 
Spermidine, 10 µL 100 mM DTT, 1 µL Triton X-100, 8 µL of each 50 mM dNTP, 16 µL 
5 x T7 polymerase buffer, 13 µL linear plasmid TCV DNA at 1µg/µL, 2 µL T7 RNA 
polymerase and 2.5 µL RNasin. A sample was run on an agarose gel for identification of 
the TCV product before use in the inoculation process. The concentration of genomic 
RNA was calculated using the absorbance at 260nm, the RNA length of 4054 bps and an 
average base weight of 330. An RNA purification procedure was not necessary before 
inoculation. A 600 µL inoculation solution was prepared with 60 µg TCV genomic RNA, 
300 µL 2 x autoclaved infection buffer containing 0.05 M glycine, 0.03 M K2HPO4 pH 
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9.2, 1% bentonite, 1% celite, and 240 µL distilled water. The 10 µL inoculation solution 
was pipeted onto each leaf and, using a sterile glass, stirring rod, rubbed gently into the 
leaf surface. All plants remained un-watered for 48 hours past the inoculation process, 
after which plants were watered heavily once a week. Symptoms became visible in two to 
three weeks past inoculation. These symptoms included the presence of lesions and 
yellowing of the older outer leaves while the dark green newer leaves were stunted and 
severely crinkled. Once at least three to four newer leaves have developed per plant these 
leaves can be harvested for virus purification. 
2. Virus Purification
The method for TCV purification from infected plant tissue was adopted and 
modified from the method by Skuzeski and Morris (37). Approximately 30 grams of 
turnip leaves were harvested at least 28 days past inoculation (dpi). Every 10 g tissue was 
added to and ground with 30 mL sap extraction buffer containing 0.2 M sodium acetate 
pH 5.2, 30 µL -mercaptoethanol, and protease inhibitor mixture (50 µM TPCK, 0.5 µM 
PMSF and 10 µg 2 –macroglobulin per mg virions) in a mortar on ice. Once 
homogenous the ground mixture was filtered through two layers of cheesecloth and the 
collected supernatant incubated on ice for 30 minutes. It was then centrifuged at 7,300 
rpm for 1 hour at 4°C in a SA-600 rotor (Sorvall) to pellet cell debris. The supernatant 
was removed and 10 mL of 40% polyethylene glycol molecular weight 6000 (PEG; 
Sigma) in 1 M NaCl was added per 40 mL supernatant. Once mixed the solution was 
incubated on ice for 30 minutes to precipitate the virions. It was centrifuged at 7000 rpm 
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for 30 minutes at 4°C using a SA-1500 rotor (Sorvall) to pellet the virions, which were 
then resuspended in 20 mL resuspension buffer containing 0.05 M sodium acetate pH 5.2 
and incubated on ice for 1 hour. The solution was centrifuged again at 7,300 rpm for 30 
minutes at 4°C in the SA-600 rotor and the supernatant removed for further 
centrifugation. The supernatant was centrifuged at 47,900 rpm for 90 minutes at 4°C 
using a Type 70 Ti Beckman rotor. The pellet containing the virions was resuspended in 
2 mL column buffer containing 0.01 M sodium phosphate pH 7.0 and 2.5 % glycerol. It 
was then briefly clarified by microcentrifugation before loading onto a DEAE-agarose 
gel A (Bio-Rad) packed 18 mL column 1.5 by 10 cm pre-equilibrated with column buffer 
at 4°C. The column was washed with 4 column volumes of column buffer and then eluted 
with a NaCl gradient (0 to 1 M NaCl) using 6 column volumes with a flow rate of 0.35 
mL per minute. Fractions were collected at 10 minute intervals (3.5 mL each) and the 
virion absorbance was determined and recorded at 280 nm by the UV/Vis detector (ISCO 
UA-6 with optical unit type 11). All fractions were checked on 12.5% SDS-
polyacrylamide gels and those fractions containing only CP were pooled. The virions 
were re-precipitated by adding a half volume of 40 % PEG supplemented with 1 M NaCl, 
mixed and allowing the solution to sit overnight at 4°C before centrifugation at 7000 rpm 
for 30 minutes at 4°C in a SA-600 rotor. The pellet containing the virions was 
resuspended in 50 mM Tris-HCl pH 8.5 at 4°C with 0.01% sodium azide and stored at 
4°C. The concentration was determined by its absorbance at 260 nm, and calculated with 
a known extinction coefficient of 50 at 260 nm for a 1% solution or 0.01 g/mL virions.
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3. Coat Protein Purification  
The method for CP purification from TCV was adopted and modified from the 
protocol by Skuzeski and Morris (37). About 4 to 5 mg virions were dissociated by 
incubating in dissociation buffer containing 0.1 M Tris-HCl, 5 mM EDTA, 1 M NaCl pH 
8.5 at 4°C, and the protease inhibitor mixture (50 µM TPCK, 0.5 µM PMSF and 10 µg 2 
–macroglobulin per mg virions) on ice for 1.5 hours. The RNA was precipitated by 
adding a 5% (w/v) PEI solution by rapid mixing to a final concentration of 0.5 mg/mL or 
0.05%. The solution was incubated on ice for 15 minutes before centrifugation at 13,000 
rpm for 10 minutes at 4°C in the microcentrifuge. It was then loaded onto a Sephacryl 
S200HR column 1.0 x 30 cm previously equilibrated with dissociation buffer. Fractions 
were collected every 10 minutes at a flow rate of 0.22 mL/minute (2.2 mL each) and the 
CP absorbance was detected at 280 nm using a UV/Vis detector. The corresponding 
samples were checked on 12.5% SDS-polyacrylamide gels and those fractions with intact 
CP lacking RNA were pooled. The pooled fractions were then dialyzed for 3 hours 
against two changes of a high salt storage buffer containing 50 mM Tris-HCl, 1 mM 
EDTA, 1 M NaCl, 5% glycerol, pH 8.5 at 4°C. The CP concentration was finally 
determined at 280 nm using a calculated extinction coefficient of 57280 M-1cm-1 and 
aliquots were stored at -70°C.    
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K. Transmission Electron Microscopy
Electron microscopy was used in order to check the size and structure of the virions 
extracted and purified from infected turnip leaf tissue. Virus concentrations of 0.4 and 0.2 
mg/mL in 50 mM Tris pH 8.5 at 4ºC supplemented with 0.01% sodium azide were 
negatively stained on carbon coated formar grids. A 5 µL drop of 0.1% bacitracin was 
applied to each grid and allowed to stand 5 seconds then wicked dry. Each diluted sample 
was then applied in a volume of 3µL and allowed to dry for 5-15 minutes. Once dry one 
drop of 2.5% uranyl acetate stain, 2.5% (w/v) uranyl acetate in distilled water, was added 
to each grid for less than 30 seconds then wicked off and dried. All prepared grids were 
visualized using a ZEISS EM 10CA transmission electron microscope by Tim Maugel at 
the University of Maryland College Park Laboratory for Biological Ultrastructure. A 
voltage of 80kV was used consistently while the magnification was varied from 50 to 160 
K. Multiple images were recorded on film and used to calculate the approximate virion 
size.   
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III. Cloning of CP gene & Expression, Purification and Characterization of 
Recombinant TCV CP
A. Introduction
Recent research has suggested that the inhibition of assembly of TCV is 
correlated to the CP’s ability to act as a suppressor of gene silencing in vivo. In particular 
it has been observed that the presence of satellite RNA C (satC) in the TCV infection is 
correlated with (1) a decrease in virion accumulation, (2) an exacerbation of symptoms, 
and (3) an increase in the suppression of gene silencing (16, 17, 38, 39). Suppression of 
the gene-silencing pathway has also been found to occur with the introduction of 
unassembled coat protein into plants infected with Green Fluorescence Protein (GFP)-
constructs via Agrobacterium infiltration. When both unassembled CP and the GFP 
constructs were introduced into Nicotiana benthamiana leaves there was a delayed 
degradation of these constructs. This was viewed visually by fluorescence of the GFP 
under long-wavelength UV light. Those leaves co-infiltrated with CP had higher levels of 
fluorescence that peaked at 5 days past infiltration (dpi) and remained at that level for a 
two-week period. Leaves infiltrated with GFP alone peaked at 2 dpi and the fluorescence 
levels started to decrease after 5 dpi. It was also observed that there was a correlation 
between the increase in the fluorescence and an increase in the levels of GFP mRNA 
isolated from the infiltrated area. The introduction of the CP suppressed the degradation 
of the GFP mRNA into siRNAs. This was verified by a lack of siRNAs present, which 
suggested that the CP is interfering in the early initiation step when Dicer degrades the 
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dsRNA into siRNAs. It was also determined that in order for the CP to act as an efficient 
suppressor it had to be present at the time of the silencing initiation (16). The TCV CP 
suppression activity was also observed in Agrobacterium-infiltrated Nicotiana 
benthamiana leaves using GFP constructs in another lab. The N-terminal 25 amino acids 
were determined to be important for this suppression activity (17). Based on these results 
it was hypothesized that the CP must be unassembled in order to act as a suppressor. 
Therefore satC may be sequestering the CP and allowing it to remain in an unassembled 
state. This would result in a decrease in the virion assembly while increasing suppression 
and consequently symptom severity. 
In order to determine if satC interferes with virion assembly an in vitro assembly 
assay must be developed and a large quantity of CP purified. The standard protocol for 
CP purification involves isolating and purifying virions from infected plant tissue, which 
are then used as the source for CP. As a result the plants must be grown, inoculated and 
become symptomatic before harvesting for virion purification. Since plants are the main 
source for virion isolation the complete process is time consuming and inefficient. The 
CP yields from the dissociated virions are also low. Therefore another method of CP 
isolation and purification had to be devised. 
There have been numerous examples of plant coat protein coding sequences that 
have been cloned into plasmids and expressed in E. coli strains in an effort to obtain 
recombinant functional protein without the time constraints and low yields associated 
with isolation from plant tissue. Both Cowpea chlorotic mottle virus (CCMV) and 
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Tobacco mosaic virus (TMV) coat proteins have been expressed in and purified from E. 
coli, specifically the BL21(DE3) strain (61, 62). In the case of CCMV, the recombinant 
coat protein was localized in the insoluble inclusion bodies and the protein was extracted 
using a denaturant, 8 M urea, before renaturing the CP into a high salt buffer (61). The 
recombinant CP from both of these viruses were tested for reassembly in vitro and 
observed to assemble (61, 62). 
Based on these previous results it was possible to clone the TCV CP gene into a 
plasmid, transform it into BL21(DE3) cells, express the recombinant CP and purify it 
from E. coli with it still remaining functional for use in assembly experiments. Once the 
CP has been purified it will need to be characterized and compared to virus derived TCV 
CP before use in assembly experimentation.                
B. Results
1. Cloning of TCV CP Sequence
In order to obtain recombinant protein the coding sequence was first ligated into 
an appropriate vector from which it could be expressed. The original TCV-MS genomic 
DNA inserted into a pUC 19 plasmid was provided by Anne Simon’s lab (University of 
Maryland, Department of Cell Biology and Molecular Genetics). The CP coding 
sequence was amplified using polymerase chain reaction (PCR) and the reaction run on 
an agarose gel. The band corresponding to the product was excised and the DNA isolated 
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via electrophoresis. The CP gene was ligated into a pGEM-T Easy PCR cloning vector 
and amplified in vivo. Once the plasmid was purified the CP coding sequence was 
excised with restriction enzymes. The coat protein sequence was cloned into the bacterial 
expression plasmid pET-17xb at which point it was amplified, purified and sequenced 
(see Figure 20A; Anne Colgrove and Beckett unpublished). Sequence alignment analysis 
with the original CP-MS and B coding sequences indicated the presence of various 
mutations in all isolates. In an effort to reduce mutations, isolates #1 and #8 were cleaved 
with the restriction enzymes HinD III and BsaA I producing two different sized 
fragments, 1.7 Kb and 2.6 Kb, that could be isolated via gel electrophoresis. The 1.7 Kb 
fragment consisting of the CP gene nucleotides #1-612 from isolate #1 and the 2.6 Kb 
fragment consisting of the CP gene nucleotides #613-1056 from isolate #8 were ligated 
together to form the complete CP DNA sequence (see Figure 20B). Sequence alignment 
analysis between the new ligated plasmid construct and the TCV CP sequences MS and B 
indicated sites of silent and missense mutations. The construct contained three missense 
mutations in the DNA sequence that would result in a change in the amino acid sequence 
of the CP to a T70, A124 and W346. The differences in the DNA sequence between the 
CP-MS and B exist at positions 209, 371 and 1037 in the gene (see Figure 21). Site-
directed mutagenesis was performed, for the three identified missense mutations, in order 
to obtain clones of both CP sequences.  
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2. Expression and Purification of TCV CP
a. Induction of CP expression from E. coli cell lines
Once clones were obtained for both TCV CP-MS and B sequences the expression 
level of the CP in different bacterial strains was investigated. A series of 5 mL CP 
expression tests were performed using the pET-17xb/TCV CP plasmids transformed into 
the cell lines BL21(DE3) and BL21(DE3) pLysS. These cultures were grown at 37°C 
with CP expression induced at a cell density where the OD600 was 0.9 by the addition of 
IPTG to a final concentration of 75 µg/mL. A 1 to 2 hour induction period resulted in 
maximum expression levels in the BL21(DE3) cell line. In order to determine the 
optimal conditions for protein expression using this cell line, including growth 
temperature and length of induction, the pET-17xb/TCV CP plasmids were once again 
transformed into the BL21(DE3) cell line and 50 mL cultures were grown at a range of 
different temperatures (37°C, 30°C, 25°C, 20°C). Expression of the CP gene was then 
induced as previously described with samples removed at each hour past the time of 
induction (1-5 hours). The samples analyzed on 12.5% SDS-polyacrylamide gels 
indicated that maximum expression of the CP occurred with a culture growth temperature 
of 25°C and an induction time of 4 hours. These parameters were then implemented in a 
500 mL protein preparation test in which it was discovered that the TCV CP was located 
in the pellet following sonication. In an effort to increase protein solubility a series of 500 
mL protein preparation tests were performed whereby the growing conditions were 
changed. Specifically, the temperature was varied (30°C, 25°C, 20°C, 37°C/25°C), and 
the ratio of insoluble to soluble protein expressed was compared (see Figure 23). 
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Figure 23. Samples from the 500 mL protein preparation tests of pET-17xb/TCV CP-MS 
in BL21(DE3) grown at varying temperatures were run on 12.5% polyacrylamide 
denaturing gels for analysis. Cultures were grown at temperatures of 30°C, 25°C, 20°C 
and 37/25°C with the samples from these protein preparation tests run on the gels A, B, 
C, and D respectively. The samples indicated in each lane are as follows for gel A: Lane 
(1) BirA marker, (2) uninduced, (3) induced, (4) post lysis supernatant, and (5) post lysis 
pellet. The sample sequence for gel B was: Lane (1) BirA marker, (3) uninduced, (5) 
induced, (7) post lysis supernatant, and (9) post lysis pellet. The samples for gels C and D 
were loaded as follows: Lane (1) BirA marker, (3) induced, (5) post lysis supernatant, 
and (7) post lysis pellet.  
It was observed that changing the temperature for bacterial cell growth did not improve 
the solubility of the coat protein. Since the solubility of the CP could not be successfully 
increased the objective became to obtain all the parameters needed for maximum CP 
expression using this strain. Therefore a series of tests were performed in order to 
determine the optimal OD600 value for induction. The main 200 mL culture was grown at 
25°C as previously described but the initial OD600 at the time of induction was varied 
from an OD600 of 0.5 to 0.9. At each point a 25 mL volume was removed from the main 
culture and expression of the CP was induced by addition of IPTG. Samples taken every 
hour after the time of induction for each culture were run on denaturing polyacrylamide 
A 1       2        3        4         5 
BirA
1       2         3        4        5        6        7
BirA
C 1        2         3        4        5        6        7  
BirA
D
B 1       2        3        4        5        6        7         8 9
BirA 38 kDa CP
35 kDa protein
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gels. The maximum level of CP expression was observed to occur by addition of IPTG to 
cultures at an OD600 between 0.7 to 0.8. The optimal induction time was 4 hours (see 
Figure 24).
Figure 24. Induction tests at 25°C of pET-TCV CP-MS transformed into BL21l(DE3). 
Gel (A) represents samples removed after induction of the CP gene at an OD600 of 0.8 at
various time points. The lanes are indicated as follows: Lane (1) BirA marker, (3) 1 hr., 
(4) 2 hr., (5) 3 hr., (6) 4 hr., (7) 5 hr., and (8) uninduced. Gel (B) represents samples taken 
from cultures 4 hours past the initial time point where the CP gene was induced. The 
OD600 at the time of induction varied as indicated: Lane (1) BirA marker, (3) 0.5, (4) 
0.6, (5) 0.7, (6) 0.8, (7) 0.9, and (8) uninduced.  
b. Protein Extraction and Chromatography (pET-17xb/TCV CP-MS in 
BL21(DE3))
Since protein solubility could not be increased by changing the growth conditions, 
the insoluble protein found in the inclusion bodies of the sonicated pellet was extracted 
using a denaturant, guanidine-HCl. Most of the protein was extracted with only a small 
amount left in the residual pellet. Once soluble the denatured protein was purified via 
chromatography. First the solubilized protein was subjected to gel-filtration 
chromatography in 4 M guanidine-HCl. Both Sephacryl S-200 and S-1000SF columns 
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were not useful in separating the CP from another protein that migrated to the 35kDa 
mark (see Figure 25). The samples containing CP were pooled and dialyzed out of 
guanidine successfully by step-wise dialysis from the 4 M guanidine sample into high salt 
buffer. The original protocol consisted of eight 1 hour dialysis steps performed against 
high salt buffer containing 3, 2, 1, 0.8, 0.6, 0.4, 0.2 and 0 M guanidine-HCl, respectively. 
Due to the amount of guanidine needed to prepare these solutions the dialysis procedure 
was modified to six steps starting with the 1 M guanidine-HCl high salt buffer. Since this 
was also successful in renaturing the protein the dialysis steps were modified to four steps 
of high salt buffer containing 1, 0.6, 0.2 and 0 M guanidine, respectively. 
Figure 25. The guanidine-HCl extracted pellet of a 500 mL pET-TCV CP-
MS/BL21(DE3) protein preparation test was run on different gel-filtration resins. The 
gels represent samples of fractions collected from both a Sephacryl S-200 (gel A) and a 
Sephacryl S-1000SF column (gel B) with a BirA marker in lane 1 of each gel. Both 
columns were run under guanidine-HCl denaturing conditions.
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In an effort to separate CP from the 35 kDa contaminant, the dialyzed protein was 
then tested under non-denaturing conditions on both Q-Sepharose and HAP resins but it 
was unable to bind to the columns. As the sample’s salt concentration was decreased 
from 1 M NaCl to 200 mM KCl the protein precipitated out of solution. As a 
consequence, once the sample was removed from denaturant the protein needed to remain 
in high salt or 1 M NaCl. This limited the type of resins that could be used for 
purification to either ion-exchange under denaturing conditions or gel-filtration under
denaturing/high salt conditions. The resulting solubilized fraction from the guanidine 
extraction was observed to consist of the 38 kDa TCV CP and a 35 kDa protein which 
could not be separated from the sample by chromatography, either gel-filtration (S-200, 
S-1000) or ion-exchange (Q-Sepharose, HAP) under different buffer conditions, or by 
using a different denaturant, 8 M urea, extraction procedure with a CM-Sepharose 
column under denaturing conditions (see Figure 26). The resins SP and Q-Sepharose and 
HAP were also tested under denaturing, 8 M urea, conditions but no separation of the CP 
from the 35 kDa protein was achieved. 
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Figure 26. All samples taken during the 500 mL protein preparation trial of pET-TCV 
CP-MS/BL21(DE3) were run on 12.5% polyacrylamide denaturing gels for analysis. 
Gel (A) represents the samples taken from the expression and urea extraction procedures 
while gel (B) indicates the fractions # 12 - 20 collected during the denaturing CM 
Sepharose column. The samples indicated in each lane are as follows for gel (A): Lane 
(1) low range standard, (2) BirA marker (3) uninduced, (4) induced, (5) post lysis pellet, 
and (6) post lysis supernatant.   
c. Characterization of the 35kDa protein
Since the two proteins were inseparable with these techniques, the 35 kDa protein 
was characterized using both N-terminal sequencing performed by Macromolecular 
Resources at Colorado State University and mass spectroscopy performed by Dr. Kristy 
Brown. It was suggested that the protein was a cleavage product of the TCV CP since 
proteases are known to cleave the N-terminal region of the CP and the 35 kDa protein 
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was behaving similar to the target. The N-terminal sequencing indicated that the 35 kDa 
protein contained a N-terminus with the first seven amino acids MENDPRV, which is 
identical to the N-terminus of the CP amino acid sequence. Mass spectroscopy was 
performed with both protein samples digested with chymotrypsin. The mass of each 
protein fragment was compared to the actual predicted digestion fragments for the CP-
MS sequence. The data indicated that the 35 kDa protein contained the same sequence as 
the TCV CP-MS except for a missing region at the C-terminus starting at the lysine at 
position 325 in the coat protein sequence (see Figure 27). 
Figure 27. Chymotrypsin digestion of 35 kDa protein. The protein was initially digested 
with chymotrypsin producing fragments that were then weighed with mass spectroscopy. 
The red lines indicate the predicted sites of cleavage for the TCV CP-MS sequence. 
Analysis determined that the 35 kDa protein was a truncated form of the CP (amino acids 
#1-325) missing part of the C-terminus. The blue arrow indicates the end of the weighed 
fragments.
From these data the calculated theoretical pIs for both the 38 kDa and 35 kDa proteins 
were determined to be 9.30 and 9.15, respectively. These values were almost identical 
making separation by ion-exchange chromatography impractical, while the size similarity 
between the proteins eliminated the possibility of separation via gel-filtration. All 
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attempts at separation using ion-exchange and gel-filtration chromatography were 
unsuccessful with either denaturant extraction method and a new approach to the problem 
had to be devised.
d. Expression and purification of the CP from the E. coli strain Rosetta(DE3)
The logical next step was to determine the reason for the presence of the 35 kDa 
protein and find a way to inhibit its production in vivo. These included two main ideas. 
Either there was an early termination site in the coat protein sequence, where the AAG 
codon for the K325 was being interpreted as a UAG stop codon, or that there were not 
enough rare transfer RNAs present in the BL21(DE3) E. coli strain population to allow 
for complete translation. Analysis of the TCV CP DNA sequence allowed identification 
of 30 rare codons, which with the low rare tRNA population could result in translational 
stalling and premature translational termination. Based on this data the coat protein gene 
was expressed in a different bacterial cell strain, Rosetta(DE3), that provided a larger 
pool of these rare tRNAs. A series of induction tests at the optimal growing conditions 
resulted in expression of the 38 kDa coat protein without the production of the 35 kDa 
early translational termination product (see Figure 28). 
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Figure 28. Induction tests of pET-TCV CP-MS transformed into Rosetta(DE3) grown at 
37°C (gel A) and 25°C (gel B) with a 4 hour induction of the CP gene starting at a cell 
density with an OD600 of 0.7 to 0.8.  Four cultures (# 1 – 4)  were grown at each 
temperature with induction by addition of IPTG to a sample from each. For each gel the 
samples are as follows: Lane (1) low range protein standard, (2) CM sepharose fraction 
from pET-TCV CP-MS/BL21(DE3) prep, (3) culture #1 uninduced, (4) culture #1 
induced, (5) culture #2 uninduced, (6) culture #2 induced, (7) culture #3 uninduced, (8) 
culture #3 induced, (9) culture #4 uninduced, and (10) culture #4 induced.
A 500 mL protein pET-TCV CP-MS/Rosetta(DE3) preparation test using the same initial 
parameters as described for BL21(DE3) was implemented. The protein was extracted 
with an 8 M urea extraction procedure and ion-chromatography performed on a CM 
Sepharose column under 8 M urea denaturing conditions. The production of the 35 kDa 
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protein had been eliminated and purification of the 38 kDa TCV CP was >98% (see 
Figure 29). HAP chromatography under denaturing 8 M urea conditions was tested to 
help increase the purity of the CP. Although the CP bound to the column and eluted, the 
purity of the sample did not increase and there was an overall dilution of the protein (see 
Figure 30). This presented a problem since the CP under these conditions could not be 
concentrated without loss in the form of aggregates. Therefore the HAP column was not 
used as an additional step in the purification procedure.  
Figure 29. All samples taken during the 500 mL protein preparation test of pET-TCV CP-
MS/Rosetta(DE3) were run on 12.5% polyacrylamide denaturing gels for analysis. Gel 
(A) represents the samples taken from the expression and urea extraction procedures 
while gel (B) indicates the fractions # 18 - 24 collected from the denaturing CM 
Sepharose column. The samples indicated in each lane are as follows for gel (A): Lane 
(1) low range standard, (2) uninduced, (3) induced, (4) post lysis supernatant, (5) post 
lysis pellet, (6) extraction supernatant, and (7) extraction pellet. 
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Figure 30. The purified CP from the CM Sepharose pooled fractions of the 500 mL pET-
TCV CP-MS/Rosetta(DE3) protein preparation test was run on a denaturing urea HAP 
column. The fractions # 33 - 40 collected from this column were run on 12.5% 
polyacrylamide denaturing gels for analysis. The samples indicated in each lane are as 
follows: Lane (1) fraction # 33, (2) low range standard, (3) CM Sepharose pooled 
fractions, (4 – 10) fractions # 34 – 40.
The purified protein from the CM Sepharose column was renatured via step-wise dialysis 
out of urea and into a high salt storage buffer. Spectroscopic measurements at 280 nm 
indicated that the protein was free of both aggregates and nucleic acid. All attempts at 
decreasing the salt concentration of the CP sample resulted in precipitation and 
aggregation of the CP over time. It was determined that once the CP was removed from 
the denaturant it had to remain in a high salt buffer containing 1 to 0.5 M NaCl at a pH 
8.0 at 4°C. A CP sample with a concentration of 11µM once dialyzed into 0.5 M NaCl 
buffer pH 8.5 at 20°C contained a small fraction of protein that precipitated out of 
solution. Therefore all samples were stored at -70°C in a 1M NaCl high storage buffer pH 
8.5 at 4°C supplemented with 5% glycerol. 
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3. Characterization of TCV CP
a. CP folding
Circular dichroism was used in order to determine if the renatured TCV CP had 
folded properly. Data were collected with the protein in a 100 mM sodium phosphate 
buffer and 100 mM sodium phosphate buffer containing 50 mM Tris-HCl, 1 mM EDTA, 
pH 8.5 at 4°C (see Figure 31). Qualitative data analysis (200-250 nm) indicated that the 
protein was folded and contained the expected secondary structures, -sheet and -helix. 
The lower wavelength range (180-200 nm) was not analyzable due to buffer interference 
and low protein concentration. 
Figure 31. CD spectra of purified TCV CP in (A) sodium phosphate, Tris buffer (100 
mM NaH2PO4/Na2HPO4, 50 mM Tris-HCl, 1 mM EDTA, pH 8.5 at 20°C) and (B) 
sodium phosphate buffer (100 mM NaH2PO4/Na2HPO4, pH 8.5 at 20°C). The wavelength 
region 180-200 nm cannot be analyzed due to buffer interference. 
A B
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The protein concentration could not be increased above a concentration of about 
10 µM without precipitation. Since buffers especially those containing sodium chloride 
can interfere with measurements at the lower wavelengths a range of buffers were tested 
for dialysis against the CP. The protein was dialyzed into different concentrations of 
sodium phosphate buffers containing 50 mM Tris-HCl and 1 mM EDTA with some 
success, although it was observed that these buffers still interfered with the lower 
wavelength measurements and protein solubility. The CP precipitated out of solution 
either as the concentration was increased, the temperature was varied or the ionic strength 
of the buffer was decreased. Therefore it was determined that sodium phosphate was not 
an ideal buffer for CD analysis of the CP due to both its inability to buffer the higher pH 
region above 7.8 and its continued interference with the instrumentation. The protein had 
the highest solubility when present in a buffer containing a high concentration of sodium 
chloride. 
In order to attain measurements in the far UV wavelength region the protein 
sample was in a 0.1 cm path length cuvette, which dictated the higher level of CP needed 
to obtain a clear signal. Since the protein concentration could not be increased without 
increasing the buffer interference and maintaining protein solubility it has been suggested 
to run CD measurements in the near UV region from 350 to 250nm where sodium 
chloride would not interfere with the protein signal. Within this range the level of the 
individual secondary structures present in the sample cannot be quantified but it is 
possible to compare the spectrum of the renatured recombinant CP with protein isolated 
directly from virions. Overlap of the two spectra would indicate that the recombinant CP 
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had folded properly. Some of the advantages of obtaining measurements from this region 
include the ability to use sodium chloride as a buffer component, allowing a higher 
concentration of soluble protein to be maintained during the measurement process.      
b. CP assembly state in solution
Sedimentation experiments, both velocity and equilibrium, were used in an effort 
to characterize the assembly state of the protein in solution. High salt buffer was used for 
these measurements. Velocity sedimentation data analysis indicated the presence of 
monomer and dimer along with other larger aggregates. The data from equilibrium 
sedimentation experiments could not be fit to a model and must be repeated. There were 
some obvious problems with the data fit during the analysis of both the velocity and 
equilibrium experiments, which was attributed to the fitting programs. Velocity 
sedimentation was repeated with protein in a 0.5 M NaCl buffer and a portion of the data 
were fit to a 1 species model, which indicated the presence of monomer (see Figure 32). 
Fitting of earlier timed scans indicated monomer, dimer and possibly larger aggregates. 
This indicates that over time the larger protein aggregates migrated to the bottom of the 
cell. There were still some problems with data fit and salt effects. These experiments will 
need to be repeated under different conditions (low salt and slower speed). The CP had 
been dialyzed into 1, 0.5 and 0.25 M NaCl buffer containing 100 mM Tris-HCl, 5 mM 
EDTA, pH 8.5 at 20°C. As the concentration of the sodium chloride was decreased the 
dialyzed CP started to form aggregates and precipitate out of solution. This was first 
observed from data analysis of the measurements collected from the sedimentation 
experiments using these buffers and was later confirmed with dialysis trials.
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Figure 32. Velocity sedimentation data of  TCV CP in 0.5 M NaCl buffer (0.5 M NaCl, 
100 mM Tris-HCl, 5 mM EDTA, pH 8.5 at 20°C) was obtained for a total of 90 scans. 
The later scans were fit to a 1 species model using (A) scans 76-90 and (B) scans 61-70. 
Data in graph (A) was fit to a monomer of molecular weight 42.26 kDa [37.45, 46.77] 
while (B) was fit to a monomer of 36.34 kDa [33.57, 39.12].  Earlier scans were fit to a 3 
species model using (C) scans 25-60. Data in graph (C) was fit to possibly monomer and 
dimer: 69.33 kDa [60.65, 76.11], 26.38 [23.55, 28.58] and 7.49 kDa [6.55, 9.43]. The top 
graphs show the time derivative -dc/dt analysis with the distribution of -dc/dt as a 
function of the sedimentation coefficient. The distribution of residuals are shown in the 
bottom  panels.
C. Discussion
1. Cloning the CP gene
Characterization and assembly of the CP, requires a large amount of material 
obtained from dissociated virions. The CP gene was therefore cloned and the 
recombinant CP expressed and purified from E. coli. The CP DNA sequence was first 
amplified using PCR and the purified DNA was then inserted into a pET-17xb plasmid 
under control of the T7 promoter. Once the DNA was amplified in vivo and sequenced, 
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analysis of the data indicated the presence of both silent and missense mutations. These 
mutations were produced as a result of PCR mistakes and/or cross-contamination. 
Problems with PCR may be attributed to a wide-range of factors including old dNTPs, 
buffers, and varied temperatures. Error may be attributed to using the PCR products as 
template for amplifying the DNA, in which case carry-over contamination would be 
responsible. Contamination of the original TCV genomic RNA sample used in 
performing reverse transcriptase PCR (RT-PCR) was most likely the main contributor to 
the mutations in the CP DNA sequence. There is also the possibility that the Taq 
polymerase introduced the mistakes into the DNA sequence since it lacks 3' to 5' 
proofreading exonuclease activity. A polymerase that contains a proofreading mechanism 
such as Pwo or Pfu could have been used instead to limit mutations (63). All missense 
mutations were corrected with site-directed mutagenesis producing both TCV CP coding 
sequences MS and B.   
2. Early Translational Termination
Initially the recombinant CP was expressed in the BL21(DE3) cell strain as 
previously performed with other plant recombinant CPs (61, 62). Inducing the CP gene 
resulted in co-expression of the full-length CP with a translational termination product 
that could not be separated from the target protein. Synthesis of this truncated product 
was correlated to the presence of specific codons in the viral plant gene. Eukaryotic 
organisms use a specific subset of the 61 available codons with a frequency different 
from that found in prokaryotes. Those major codons that occur in highly expressed E. coli
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genes are used with higher frequencies than rare codons present in genes expressed at 
relatively low levels within E. coli. The codons with a low frequency of use in E. coli can 
be found to occur with a higher frequency in other organisms. As a result most E. coli
strains do not contain the necessary concentration of transfer RNAs (tRNAs) needed for 
expression of the heterologous protein from its mRNA (64). Analysis indicated the 
presence of seven rare codons used repeatedly throughout the CP coding sequence. The 
DNA contained a total of 30 codons that E. coli normally does not require the appropriate 
tRNAs for in order to keep up with translation (see Figure 33).  This resulted in the 
synthesis of the 35 kDa translational termination product missing the C-terminus of the 
CP starting after K325 (see Figure 34). The early termination may be correlated to either 
the presence of the downstream rare codon cluster AGG/GGA, such clusters have been 
shown to terminate translation, or the misinterpretation of the AAG lysine codon as a 
UAG stop codon (64). Two different approaches to eliminate synthesis of the truncated 
product included either replacing all 30 of the rare codons with major codons or 
transforming the plasmid into an E. coli strain designed to supply the necessary tRNAs 
for complete translation. Since it would be too time consuming to change all the 
appropriate codons, a different strain was implemented in the expression process. The 
protein was therefore expressed in the Rosetta(DE3) strain (Novagen) which supplied six 
of the seven rare tRNAs needed for complete translation of the CP gene (see Figure 33). 
It was not necessary to change the four rare CGA codons, which the corresponding 
tRNAs were not supplied by the Rosetta(DE3) strain, since expression in the new strain 
eliminated production of the 35 kDa protein. 
87
Figure 33. A table indicating the codons used by E. coli at a frequency of <1% and the 
amino acids encoded by these rare codons. The * identifies those codons that 
Rosetta(DE3) supplies tRNAs for. The rare codons found in the TCV CP sequence are 
recorded by the number of each present (61). 
Figure 34. This represents the site of truncation for the 35 kDa translational termination 
product. 
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3. Expressed CP insolubility
After expression the CP was still found in the insoluble inclusion bodies within 
the post-lysis pellet. This insolubility is not uncommon in the overexpression of 
recombinant proteins. Normally in the cell the native fold and solubility of the expressed 
protein is mediated by chaperone proteins. Solubility is influenced by both the protein’s 
affinity for chaperone(s) and the ratio of the two present in the cell. A high level of 
expressed protein may exceed the chaperone system’s capacity allowing some 
overexpressed protein to sequester all available chaperones while the rest has a chance to 
misfold and consequently become packaged into inclusion bodies (65). The solubility 
level may also be dictated by the protein structure. It has been observed that the capsid 
protein has a high affinity for self-association resulting in aggregation and association 
with other RNA, decreasing the chance of the protein staying soluble for an extended 
time in the cell. The basic positive charge associated with the protein N-terminus 
attributes to the overall protein insolubility. It has been observed that exported proteins 
translocated across the cytoplasmic membrane in gram-negative bacteria have either a net 
positive or neutral charge at the N-terminus.  When the net charge increases in positive 
charge the exportation of the protein across the cytoplasmic membrane decreases (66). 
Studies have suggested that a net positive charge on a 18 to 30 residue sequence at the 
protein N-terminus will decrease the degree of translocation across the membrane (66, 
67). The first 41 residues of the CP basic N-terminus R domain has a net charge of +5 
while the first 30 amino acids contains a +3 charge. This suggests that the positive charge 
on the CP N-terminus prevents protein secretion into the cytoplasm. From the CP 
structure and behavior it was predictable for the overexpressed protein to remain 
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insoluble in the post-lysis pellet. Once the cells were lysed, as with CCMV CP, the 
recombinant TCV CP was extracted via 8 M urea (61). Protein was then purified under 
these same denaturing conditions on a CM Sepharose column (56). The fractions 
containing purified CP were pooled and dialyzed step-wise out of urea and into a high 
salt 1 M NaCl buffer. From experimentation it had been observed that the CP starts to 
aggregate and precipitate out of solution as the salt concentration is decreased below 1 M 
NaCl. Therefore the CP was stored in a 1 M NaCl high salt storage buffer pH 8.5 at 4°C 
supplemented with 5% glycerol. 
4. CP Structure
a. CP interactions in solution
Before the CP could be used in assembly experiments it needed to be determined 
if the recombinant CP had attained its native conformation once it was dialyzed out of the 
denaturant. The CP was partially characterized with respect to its renatured folded and 
assembly state in solution using both CD and ultracentrifugation measurements, 
respectively. Both CD and sedimentation analysis exhibited limitations in characterizing 
the protein. From sedimentation it was observed that the protein in a 0.5 M NaCl buffer 
consisted of monomers and larger CP aggregates. This was not unexpected since the CP’s 
main function is to assemble into the larger capsid structure and such aggregation has 
been observed with other plant capsid proteins such as Tobacco mosaic virus (19). It has 
been previously observed that TCV dissociated under mild conditions, 0.5 M NaCl, 0.1 
M Tris, 0.01 M EDTA, pH 8.3, will produce CP dimers in solution. This has been 
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previously determined both with gel-filtration chromatography, Ultrogel ACA-54, under 
these conditions and DMS cross-linking of the dissociated TCV (8). The protein structure 
also suggests dimerization due to the P domain’s susceptibility for hydrophobic 
interactions with polar groups forming hydrogen bonds and salt bridges (68). The 
formation of these dimers through interaction between the P domains was observed by 
DMS cross-linking experiments (8). Analysis of the surface contacts between adjacent P 
domains indicate that TCV has a high percentage of hydrophobic and aromatic 
interactions, with a lower percentage of polar and charge interactions. These percentages 
were 57, 29 and 7 %, respectively. These contact residues are not conserved between 
different viruses even within the same family as observed with Carnation mottle virus
(CarMV), Tomato bushy stunt virus (TBSV), and TCV from the family Tombusviridae
(69). CP P domain deletions have resulted in both a lack of assembly and systematic 
movement (13, 70). The P domain and its dimerization is essential for viral assembly. 
The CP has been observed to form dimers in solution under certain buffer conditions and 
concentrations that do not favor further association (8). Since a reasonable amount of 
protein is required for sedimentation experiments this concentration may be too high to 
exhibit only dimerization of the CP. With the increase in the concentration there is a 
higher probability for the presence of larger CP assembly states. The concentration 
threshold for the transition of the CP association from dimers to larger aggregates needs 
to be identified for future experimentation. 
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b. Native Conformation
The folded state of the recombinant CP was also not completely defined although 
the CD spectra in the far UV wavelength region contained the characteristics of -sheet 
and -helix, both of which are found in the known protein structure. The spectra did not 
contain the characteristic for random coil, which would have indicated that the protein 
was still denatured. It is not known if the protein had folded into its native conformation. 
The native CP structure consists of mainly -sheet where the S domain contains the eight 
stranded anti-parellel -sheet in the -barrel jelly roll motif with 2 small -helices and 
the P domain contains ten -strands (69). The R domain is unstructured in unassembled 
CP and as a result it has not been able to be crystallized (4).   
In order to compare the folded structure of both CPs the spectra from the CD 
analysis of the proteins in the near UV wavelength region must be analyzed for overlap. 
If the spectra are identical then the recombinant CP has been folded properly and will 
function/assemble in the same manner as the virion isolated CP. It is important that the 
protein folds properly so that the putative calcium-binding site (CBS) is formed. Each 
pair of CP subunits must bind a calcium ion in order to form and stabilize the virion 
structure. The CBS is located adjacent to the 5 amino acid hinge between the S and P 
domains. Each Ca2+ is bound by the 3 residues Asp155, Asp157 and Lys160 from one 
subunit and the two residues Gln127 and Asp199 from the other (9). It has been 
suggested that the CBS is stabilized by two salt bridges: one cation-mediated salt bridge 
and the other a Lys-Asp salt bridge (12). The presence of the CBS allows the virus to 
disassemble and release its RNA in the low calcium environment of the cytoplasm (9). 
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Therefore the folded structure of the S domain with the CBS is required for assembly. To 
determine if the recombinant CP contains the CBS site virions and CP needed to be 
isolated and purified from infected plant tissue before beginning the investigation into the 
TCV assembly mechanism.                  
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IV. Virion and Coat Protein purification from plants
A. Introduction
Since the recombinant CP was obtained and purified from E. coli it had to be 
characterized both with respect to its folded and assembled state in solution. Comparison 
between the CP isolated from virions and recombinant CP would determine if the 
recombinant CP could reassemble in vitro. Therefore, before characterization can 
continue virions and CP needed to be extracted and purified for analysis. 
Previously CP has been purified from virions isolated from infected tissue of both 
turnip (brassica campestris) and Arabidopsis thaliana plants. The plants were inoculated 
with TCV and once symptomatic, harvested for the isolation/purification of the virions. 
The purified virions were then dissociated allowing for the extraction and purification of 
the CP. The Morris lab developed a protocol for the purification of both the virions and 
CP from infected turnip plants (37). The original chromatography resin Ecteola cellulose 
(Sigma) involved in the purification of the virions was substituted with a DEAE-agarose 
gel A resin (Bio-Rad) by the Simon lab (37, 51). The remainder of the virion and CP 
purification followed Morris’ protocol (37). 
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B. Results
1. Virus purification
Virions were purified from plant tissue using a modified version of the 
purification procedure from the Morris lab (37). Plants were grown as previously 
described although the time and part of the plant to be harvested was not well defined in 
the previous method. Leaves were not harvested until at least 28 days past inoculation 
(dpi) when the newer leaves had completely developed. These leaves were severely 
crinkled and stunted while the older leaves became yellowed with visible lesions. Unlike 
the original method by Morris, in which the whole turnip plant was homogenized with 
extraction buffer, only the newer leaves were harvested (37). The main vein from each 
leaf was removed with a razor blade prior to weighing. This allowed for easier 
pulverization of the plant material into a homogenous mixture with the extraction buffer 
containing 0.2 M sodium acetate pH 5.2, -mercaptoethanol and protease inhibitors. 
The method of extraction and chromatography followed the protocol described in 
the Experimental section. After extraction the virions were precipitated using a 40% 
PEG/ 1 M NaCl solution and centrifuged producing a dark green and white pellet. This 
pellet was resuspended in resuspension buffer containing 0.05 M sodium acetate pH 5.2, 
incubated on ice and centrifuged again in order to remove large debris present in the 
sample. The light green supernatant containing the virions was then pelleted using the 
ultracentrifuge and resuspended with column buffer in preparation for purification on a 
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DEAE-agarose gel A column (see Figure 35). The virions were bound to the column, 
washed with column buffer containing 0.01 M sodium phosphate pH 7.0 with 2.5% 
glycerol and finally eluted with a linear sodium chloride gradient. Fractions containing 
pure virions, identified by absorbance at 260 nm and CP migration on SDS-
polyacrylamide gels, were pooled and the virions precipitated with PEG (see Figure 36). 
Figure 35. The TCV purification samples run on a 12.5% SDS-polyacrylamide gel. The 
samples were loaded onto the gel as follows: Lane (1) low range standard, (2) pellet # 1, 
(3) supernatant # 1,  (4) pellet # 2, (5) supernatant # 2, and (6) resuspended pellet. The 
pellet/supernatant were produced as indicated: (# 1) after the first sample centrifugation 
at 7, 300 rpm for 1 hr. at 4°C, and (# 2) after addition of the 40% PEG/1 M NaCl solution 
and centrifugation. The resuspended pellet was loaded onto the DEAE-agrose gel A 
column for purification. 
Figure 36. Fraction samples from the DEAE-agarose gel A column were run on 12.5% 
SDS-polyacrylamide gels. The fractions # 36 – 52 were run on these gels although only 
the fractions # 42 – 46 ( Gel A lanes # 8, 9 and Gel B lanes # 1-3) contained purified 
TCV. 
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The method precipitated the virions by addition of ¼ volume 40% PEG/1 M NaCl 
solution with mixing, and incubation on ice for 30 minutes followed by centrifugation. 
The pellet was then resuspended in a 2 mL volume of 50 mM Tris-HCl pH 8.5 at 4°C 
supplemented with 0.01% sodium azide. It was determined by the absorbance at 260 nm 
that the pooled fractions contained a total of 5.55 mg of virions. After precipitation the 
resuspended pellet contained only 0.804 mg of virions, with the remainder still present in 
the supernatant. In order to extract all the virions the PEG precipitation procedure was 
repeated and the combined total of both trials resulted in 4.82 mg of isolated virions from 
the initial 5.55 mg of virions. In a second preparation the following modification was 
used: addition of ½ volume of 40% PEG/1 M NaCl solution with mixing and incubation 
overnight at 4°C followed by centrifugation as previously described. The DEAE-agarose 
gel A pooled fractions containing 11.97 mg of virions once precipitated and resuspended 
using the modifications resulted in a solution containing 10.554 mg of virions. The 
overall loss was decreased significantly by increasing the ratio of PEG added to the 
sample volume. The resuspended pellet was checked on both SDS-polyacrylamide and 
agarose gels. The ethidium bromide stained agarose gel indicated that there was other 
nucleic acid present in the resuspended virion sample. Treatment of the TCV sample with 
either DNase I or RNase resulted in identification of the nucleic acid as additional RNA 
(see Figure 37). The presence of this nucleic acid may be due to the increased PEG 
concentration in the precipitation. Previously the final resuspended pellet was not 
checked on agarose gels using ethidium bromide staining, so there is no precedent for 
comparison. Since the sample contained additional nucleic acid besides the genomic 
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RNA the concentration calculations dependent on the absorbance level at 260 nm were 
not accurate.
Figure 37. Purified TCV on a native 0.6% High Strength Agarose gel. The samples were 
loaded as follows: Lane (1) 1 Kb marker, (2) TCV purified, (3) TCV treated with DNase 
I, and (4) TCV treated with RNase. 
Virion samples stored at 4°C for several months resulted in noticeable 
degradation of the capsid over time. The samples could not be stored at -20°C due to 
degradation of the virion capsid structure. Images of negatively stained virion samples on 
carbon coated formar grids were obtained using transmission electron microscopy (TEM) 
and captured on film (see Figure 38). A virion of ~ 30nm diameter was calculated from 
these images and agrees with the known capsid size. These data can be compared in 
future experimentation to the images of reassembled virions from recombinant CP. 
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Figure 38. TEM images of purified TCV virions 0.2 to 0.4 mg/mL. The bars represent 
300 nm.
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2. Coat protein purification from virions
The CP was purified from the dissociated virions following the method by the 
Morris lab (37). After the virions were dissociated a few modifications in the method 
were implemented in order to increase the efficiency of the procedure. After the virions 
were dissociated and precipitated with a 5% PEI solution the sample was centrifuged for 
10 minutes at 13,000 rpm in a microcentrifuge and the supernatant loaded onto the 
Sephacryl S-200HR gel-filtration column. However, it has been observed that CP will 
aggregate as the concentration of sodium chloride is decreased below 1 M. In order to 
increase the efficiency of separation the 0.5 M NaCl was replaced with a 1 M NaCl 
buffer. The column was run with the 1 x dissociation solution containing 1 M NaCl, 0.1 
M Tris-HCl, 5 mM EDTA, pH 8.5 at 4°C. Once the fractions containing CP were pooled 
(see Figure 39) instead of reprecipitating the CP, resuspending the pellet and dialyzing 
the sample 16 hours against two changes of a 0.01M Tris-HCl, 25 mM NaCl, pH 8.0 
buffer as indicated in the original method, the pooled fractions were dialyzed for 3 hours 
against two changes of a high salt storage buffer containing 50 mM Tris-HCl, 1 mM 
EDTA, 1 M NaCl, 5% glycerol, pH 8.5 at 4°C. This is the same high salt storage buffer 
used for recombinant CP. From an initial sample containing 4.22 mg of virions the 
amount of CP successfully extracted and purified was about 2.81 mg. This is close to the 
theoretical value of 3.54 mg which is based on the assumption that 84% of the virion is 
composed of CP. The difference between the two values may be attributed to either a loss 
of the CP during precipitation of the RNA or an incorrect estimate of the initial virion 
concentration.     
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Figure 39. All samples from the fractions # 4 – 14 of the gel-filtration Sephacryl S-
200HR column were run on 12.5% polyacrylamide denaturing gels for analysis. The CP 
eluted off the column in fractions # 6 – 10 although only fractions # 7 and 8 contained the 
majority of the protein. Samples were loaded as follows: Gel A lane (1) low range 
standard, (2) purified recombinant CP, (3) loaded supernatant, (4 – 8) Fractions # 4 – 8. 
Gel B lane (1 – 2) Fractions # 9 – 10, (3) loaded supernatant, (4) low range standard, (5 –
8) Fractions # 11 – 14.
3. TCV genomic RNA
a. Isolation of genomic RNA from virions
In order to perform assembly experiments both with the recombinant and 
functional CP genomic RNA needed to be isolated and purified. The Harrison lab 
developed a method for the isolation and extraction of the genome from dissociated 
virions (34). A sample containing purified virions was incubated in a buffer containing 1 
M Tris-HCl, 5 mM EDTA, pH 8.0 preincubated with 10 µg proteinase K per mL. The 
EDTA caused the virions to swell and the proteinase K degraded the protein allowing for 
extraction of the interior RNA. The RNA was extracted twice with phenol: chloroform 
and the aqueous layers containing the nucleic acid were moved to a separate eppendorf 
tube. Any residual chloroform was extracted once with ether and the RNA was ethanol 
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precipitated and resuspended in a 1 x TE buffer. The purified RNA was checked on a 
native 1% agarose gel and although the RNA was observed to migrate as one main band 
above the 2 Kb marker there was evidence of RNA degradation (see Figure 40A). Even 
though solutions and equipment were treated for RNase prior to use degradation was still 
visible. There were two main concerns with this method including the presence of RNA 
degradation and the low concentration of purified RNA. Since only about 16% of each 
virion consists of the genome it would require a large concentration of virions to acquire 
the necessary amount of intact purified RNA for experimentation.  
b. Synthesis and purification of genomic RNA
As an alternative the genomic RNA was synthesized using the pUC19/TCV 
plasmid cut with Sma I as the linearized DNA template. The genomic RNA was then 
synthesized using this template under control of the T7 promoter. Initially all solutions 
were prepared in the lab using DEPC-treated autoclaved distilled water. The RNA was 
synthesized in a 100 µL reaction volume containing 3 µL 1 M Tris-HCl pH 8.0, 16.5 µL 
150 mM MgCl2, 2 µL 100 mM Spermidine, 10 µL 100 mM DTT, 1 µL Triton X-100, 8 
µL of each 50 mM dNTP, 16 µL 5 x T7 polymerase buffer, 13 µL linear plasmid TCV 
DNA at 1µg/µL, 2 µL T7 RNA polymerase and 2.5 µL RNasin. It was then incubated in 
a water bath at 37°C for 3 hours. Once run on a native agarose gel the RNA was observed 
to migrate as a main single band although after purification the RNA showed signs of 
degradation (see Figure 40B). 
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Figure 40. TCV genomic RNA was run on 1% native agarose gels. The RNA extracted 
from the virions was run on gel A while the RNA synthesized for plant inoculations was 
run on gel B. Both samples were run against a 1 Kb marker.
In an attempt to increase synthesis efficiency and limit degradation a MEGAscript kit 
(Ambion) was used in conjunction with RNase free tubes and tips (Ambion). As a result 
there was an increase in the concentration of the synthesized RNA, which was observed 
on denaturing 1% agarose-formaldehyde gels. Degradation of the RNA was still visible 
after purification (see Figure 41). Three different purification techniques were used in an 
attempt to decrease degradation. These included a lithium chloride precipitation, a 
phenol: chloroform extraction followed by an ethanol precipitation and the use of a 
MEGAclear kit (Ambion). All three procedures introduced degradation into the sample, 
which indicated that a common component, the 100% ethanol, was the most likely cause 
of the continued degradation (see Figure 42). Once the 100% industrial brand was 
replaced with 99.5% ACS grade ethanol, the lithium chloride and phenol: chloroform 
purification techniques had a noticeable decrease in the RNA degradation while the 
MEGAclear kit still showed signs of degradation (see Figure 43). Since the lithium 
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chloride precipitation technique is shorter and consists of fewer steps for potential loss of 
RNA it was chosen as the final purification method for the RNA.
Figure 41. Samples of the genomic RNA from the MEGAscript and MEGAclear kit were 
run on a 1% denaturing fromaldehyde-agarose gel. Lane (1) positive control, (2) TCV 
RNA synthesized, (3) TCV RNA DNase I treated, and (4) TCV RNA purified with kit.
Figure 42. Samples of the synthesis and different purification techniques of the genomic 
RNA were run on a denaturing 1% Formaldehyde-agarose gel. The samples were loaded 
as follows: Lane (1) positive control, (2) TCV RNA DNase I treated, (3) LiCl 
precipitated, (4) phenol: chloroform/ ethanol precipitated, (5) MEGAclear kit, and (6) 
TCV RNA synthesized.  
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Figure 43. RNA samples from different purification procedures using the 99.5% ACS 
grade ethanol were run on 1% denaturing formaldehyde-agarose gels. Gel A lane (1) 
TCV RNA synthesized, (2) TCV RNA DNase I digested, and (3) TCV RNA purified 
with MEGAclear kit. Gel B lane (1) TCV RNA DNase I digested, (2) TCV RNA DNase I 
digested at room temp., (3) LiCl precipitated, (4) phenol: chloroform/ ethanol 
precipitated, and (5) TCV RNA synthesized. 
C. Discussion 
1. CP Purification
The CP has been successfully extracted and purified from infectious virions. A 
few problems with the method were identified and modified for both virion isolation and 
CP purification. The procedure for virion purification was essentially the same except for 
the ratio of 40% PEG/ 1 M NaCl added to the final purified sample to reprecipitate the 
virions. This volume was doubled since it was observed that the majority of the virions 
were retained in the supernatant upon addition of a ¼ volume of 40% PEG solution. This 
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volume was increased to an addition of ½ volume of 40% PEG, which succeeded in 
precipitating all of the virions. Analysis identified the presence of other nucleic acid in 
the final purified sample, which affected the concentration calculations based on the 
absorbance at 260 nm. This nucleic acid was identified as supplementary RNA since it 
was successfully degraded with the addition of RNase. There was the possibility that any 
degraded genomic RNA that was not completely purified from the virions was 
reprecipitated with the PEG addition. Since the final sample has not been previously 
checked on agarose gels for identification of a single band corresponding to the virus 
there is no precedent for comparison. Therefore it cannot be determined if the 
supplementary RNA present is from the increase in the PEG precipitation. Although the 
RNA did have an effect on the virion concentration calculations the presence of this 
additional RNA did not affect either the electron microscopy images or purification of the 
CP. In order to keep the purified CP under the same conditions as the recombinant 
protein the column buffer was changed so that the CP was eluted in a 1 M NaCl high salt 
buffer. It has been observed that with decreasing salt the CP aggregates. To limit this 
aggregation and allow the CP to elute off the column a higher salt concentration was used 
for the buffer. Both the purified CP and the recombinant form were stored in the same 
buffer conditions, which will allow for easier comparison. 
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2. Isolation of Genomic RNA
Characterization of this protein compared to the recombinant will determine if the 
recombinant CP is in its native conformation and retains its ability to reassemble. Both 
can also be compared through virion reassembly experiments in vitro. Reassembly occurs 
between the CP and genomic RNA in a ratio of one molecule of the genomic RNA to 180 
CPs to form a single virion. To visualize the virions on agarose gels about 1 µg RNA is 
needed compared to electron microscopy, which requires a virion concentration of 0.4 to 
0.2 mg/mL or 0.064 to 0.032 mg/mL of genomic RNA. The high yield of purified 
recombinant CP was successfully expressed and purified from E. coli. When the genomic 
RNA was purified directly from dissociated virions the presence of RNA degradation 
resulted in a low final yield. Since only 16% of each virion consists of the genomic RNA 
a large initial concentration of purified virions would be required to obtain enough intact 
purified RNA for experimentation. Therefore the RNA was synthesized from the TCV 
genomic DNA template with T7 RNA polymerase, specifically using a MEGAscript kit, 
and the RNA was purified via a lithium chloride precipitation technique.  
3. Reassembly of TCV in vivo
The purified synthesized genomic RNA and the recombinant CP can be used in 
reassembly experiments in an effort to develop an in vitro assembly technique. This can 
be used for identification of the role of satC in the inhibition of the virion assembly 
mechanism. These experiments may start off using the reassembly conditions for 
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dissociated virions (34). Once conditions for the functional CP and RNA assembly are 
established these parameters can then be implemented with the recombinant CP. 
Comparison between the virions assembled in both cases to actual TCV virions by 
electron microscopy will indicate the success of the procedure. Once an in vitro method 
has been developed the addition of satC into the reaction will determine if the satellite 
RNA can directly interfere with assembly. This will give some insight into the first part 
of the current hypothesis, which proposes that satC interferes with virion assembly, 
thereby decreasing the virion accumulation.  
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